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ABSTRACT 
Efficient and accurate localization of membrane proteins is essential to all cells and 
requires a complex cascade of interactions between protein machineries. This is 
exemplified in the recently discovered Guided Entry of Tail-anchored protein pathway, in 
which the central targeting factor Get3 must sequentially interact with three distinct binding 
partners (Get4, Get1 and Get2) to ensure the targeted delivery of Tail-anchored proteins to 
the endoplasmic reticulum membrane. To understand the molecular and energetic 
principles that provide the vectorial driving force of these interactions, we used a 
quantitative fluorescence approach combined with mechanistic enzymology to monitor the 
effector interactions of Get3 at each stage of Tail-anchored protein targeting.  We show that 
nucleotide and membrane protein substrate generate a gradient of interaction energies that 
drive the cyclic and ordered transit of Get3 from Get4 to Get2 and lastly to Get1. These 
data also define how the Get3/Tail-anchored complex is captured, handed over, and 
disassembled by the Get1/2 receptor at the membrane, and reveal a novel role for Get4/5 in 
recycling Get3 from the endoplasmic reticulum membrane at the end of the targeting 
reaction.  These results provide general insights into how complex cascades of protein 
interactions are coordinated and coupled to energy inputs in biological systems. 
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Proteins containing transmembrane domains (TM or TMD) comprise ~30% of the 
proteome and carry out essential functions in all cells. Across all kingdoms of life, 
conserved protein-targeting machineries ensure the accurate and efficient localization of 
membrane proteins to various cellular compartments.  Although the well-characterized 
co-translational Signal Recognition Particle (SRP) pathway delivers numerous 
Endoplasmic Reticulum (ER)-destined proteins, many membrane proteins utilize post-
translational targeting pathways whose mechanisms remain elusive.  A recent example is 
tail-anchored (TA) proteins1,2, which contain a TMD at the end of their C-terminus. TA 
proteins comprise a significant subset of the eukaryotic membrane proteome and play 
essential roles in numerous processes including protein translocation, vesicular 
trafficking, protein homeostasis, and programmed cell death 3. Due to the location of the 
TMD at the end of the protein coding sequence, TA proteins cannot utilize the co-
translational SRP pathway and instead must use post-translational pathways for correct 
localization to their cellular compartment. 
 In the newly discovered Guided Entry of Tail-anchored protein (GET) pathway, a 
sophisticated set of protein machineries facilitates the delivery of TA proteins to the ER 
membrane (Figure 1). Targeting via the Get pathway results in a topology where the C-
terminus of TA proteins is in the lumen of the ER and the N-terminus is facing the 
cytosol.  Once at the membrane, TA proteins are either retained in the ER bilayer or 
further trafficked to their final destination using the targeting machinery of the secretory 
pathway. 
 After protein translation is complete, TA proteins are initially bound by the yeast 
protein chaperone Sgt2 4 (or metazoan SGTA,  step1). The Get4/5 complex (or 
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mammalian TRC35/Ubl4a) then enables transfer of the TA substrate from Sgt2 onto Get3 
(mammalian TRC40, step 2-3) 4,5the primary chaperone in the GET pathway. The 
Get3/TA targeting-complex is then recognized by the Get1/2 receptor on the ER 
membrane (step 4). After stable association with Get1/2, TA protein is dislodged from 
Get3 and is inserted into the membrane bilayer 6-9(step 5). Release of Get3 from Get1/2 is 
then needed to recycle it for further rounds of TA targeting (step 6). The deletion of Get3 
significantly compromises growth in budding yeast, and knockout of the Get3 homologue 
Trc40 results in embryonic death in mammals6,10,11. This provides strong evidence that 
the Get3/Trc40 component is absolutely required for proper cell function. 
Figure 1. Overview of Tail-anchored protein targeting by the GET pathway in budding yeast. 
Details described in text. ‘?’ highlight unresolved questions. 
 
 The GET pathway requires a complex cascade of substrate capture, loading, 
delivery, release, and insertion events, whose underlying molecular basis remains unclear. 
Many questions arise: given that Get3 has three distinct binding partners with 
overlapping binding sites (Get4, Get1 and Get2), what drives the unidirectionality of this 
pathway (Figure 2), and what ensures the spatial and temporal accuracy of these 
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interactions? How does Get3 detach from Get4/5? How is Get3 recognized by Get1/2? 
Why are two subunits required in the Get1/2 receptor, and how is Get3 recycled at the 
end of the targeting reaction? 
Figure 2. The GET pathway directionality problem. Cartoon depiction of the molecular events that 
must take place in order for Get3 to transit from the cytosol to the ER membrane in a 
unidirectional manner. 
 
 
  
An important clue to addressing these issues is that the energy from ATP 
hydrolysis is required for TA targeting 6,7.  Through a series of seminal publications   
from the Hegde and Weissman groups 6,12, the ATP requirement was isolated to the 
Get3/TRC40 chaperone, a highly conserved ATPase homodimer that coordinates TA 
delivery in the GET pathway. Extensive structural work has revealed that nucleotide 
binding to Get3 regulates the conformation of its dimer interface, which leads to closure 
of its helical domains. This generates a range of structures, from open states in apo-Get3 
in which the helical domains are spread apart, to more closed states in AMPPNP- or 
ADP•AlF4--bound Get3 in which the helical domains form a hydrophobic interface 
proposed to bind the TMD of TA substrates 2,13,14. Moreover, the Get1 cytosolic domain 
has strong affinity for open, nucleotide-free Get38,9, demonstrating that Get3’s 
conformational state is subject to regulation by its interaction-partners in the GET 
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pathway. These results suggest that the Get3 ATPase could couple nucleotide- and 
effector-induced changes in its dimer conformation to TA protein binding and release. 
 Despite a plethora of structural and genetic data, the molecular mechanisms 
responsible for Get3- dependent TA protein targeting are poorly understood. Until a 
recent publication from our lab3, even basic information, such as when, where and how 
ATP binding and hydrolysis occur in this pathway, had not been addressed. Secondly, 
both open and closed conformations were observed with ADP- and Get2-bound Get3 8,15, 
raising questions as to Get3’s ability to specifically generate nucleotide- or effector-
driven conformational changes. Thirdly, while the predominant model for TA protein 
binding invokes a closed Get3 dimer, there is also evidence for tetrameric Get3 16 in 
which the TA substrate can be enclosed in a large hydrophobic chamber (Fig. 1, brackets). 
Whether and how a Get3 tetramer functions in TA protein targeting have been unclear. 
Most importantly, given the complex cascade of molecular events that must be 
coordinated by Get3, it is difficult to rationalize how Get3 is able to recognize its various 
effector proteins with a simple two-state (open to closed) conformational model. The goal 
of this thesis is to address these outstanding questions, in order to gain a deeper 
understanding of the energetic driving forces and molecular mechanisms that underlie 
this fundamental and essential cellular process. 
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Chapter 2 
 
Precise Timing of ATPase Activation Drives 
Targeting of Tail-anchored Proteins 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A version of this chapter was first published in PNAS (2013 May 7;110(19):7666-71), 
was written by Michael E. Rome, Meera Rao, William M. Clemons and, Shu-ou Shan. 	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Abstract 
 
Tail-anchored (TA) proteins, whose transmembrane domain resides at their 
extreme C-terminus, comprise 3–5% of the membrane proteome and perform numerous 
essential cellular functions. Their proper localization requires sophisticated post-
translational targeting mechanisms that are still poorly understood. In eukaryotic cells, 
the highly conserved ATPase Get3 coordinates the delivery of TA proteins to the 
endoplasmic reticulum (ER). How Get3 uses its ATPase cycles to drive this fundamental 
process remains elusive. Using mechanistic enzymology and biophysical methods, we 
establish a quantitative framework for the Get3 ATPase cycle and show that ATP 
specifically induces multiple conformational changes in Get3 that culminate in its 
ATPase activation through tetramerization. For the first time, we demonstrate that 
upstream and downstream components actively regulate the Get3 ATPase cycle. The 
Get4/5 TA loading complex, induces Get3 into a conformation in which it is locked in the 
ATP-bound state and primed for TA protein capture, whereas the TA substrate induces 
tetramerization of Get3 and activates its ATPase reaction 100-fold. Together, these 
allosteric regulations ensure the precise timing of ATP hydrolysis in the GET pathway.  
Our results establish a precise model for how Get3 harnesses the energy from ATP to 
drive the membrane localization of TA proteins, and provide new insights into how 
dimerization-activated nucleotide hydrolases regulate diverse cellular processes. 
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  Proper localization of membrane proteins is essential for the structure and 
function of all cells. Tail-anchored (TA) proteins, which contain a single transmembrane 
domain at their extreme C-terminus, constitute 3-5% of the membrane proteome 1 and 
mediate diverse cellular processes including protein translocation, vesicular transport, 
and protein quality control 1,17. Due to their topology, TA proteins cannot engage co-
translational protein targeting machineries and instead must use post-translational 
mechanisms for efficient and accurate delivery to the target membrane 1,18.  
Recent work identified the GET (Guided Entry of Tail-anchored proteins) 
pathway, in which a sophisticated protein interaction cascade mediates the delivery of TA 
proteins to the endoplasmic reticulum (ER) 1,6,12,17. Following translation, TA proteins are 
initially captured by the chaperone Sgt2 in yeast 4,5 or the BAG6 complex in mammalian 
cells 19. Sgt2 (or Bag6) then interacts with the Get4/5 complex (or its mammalian 
homologue TRC35/Ubl4a), which also binds the Get3 ATPase (or its mammalian 
homologue TRC40) 6,20. Through mechanisms yet to be determined, Get4/5 enables the 
loading of TA protein from Sgt2 onto Get3, the central ATPase in the pathway 4,7. The 
Get3/TA complex then binds its receptor, the Get1/2 complex on the ER membrane, upon 
which the TA protein is released from Get3 and inserted into the membrane 6,8,9.  
TA protein insertion is an ATP-dependent process 18 driven by the Get3/TRC40 
ATPase 6,12, a member of the SIMIBI class of nucleotide hydrolases that mediate diverse 
cellular processes 2. Twenty-one Get3 structures, solved in various nucleotide states, 
suggest how nucleotide binding to Get3 can be coupled to TA protein binding and release. 
Get3 is an obligate homodimer 13,14, and nucleotide occupancy in its ATPase domain 
allows adjustments at the dimer interface that are amplified into larger displacements of 
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its helical domains. This leads to various structures, from open conformations in apo-
Get3 in which the helical subdomains are separated, to more closed conformations in 
AMPPNP- or ADP•AlF4–-bound Get3 in which the helical domains form a contiguous 
hydrophobic groove proposed to mediate TA protein binding 13,14,21-23. In addition, the 
Get1 cytosolic domain preferentially binds apo-, open Get3 8,9,24, strongly suggesting that 
Get1 promotes the release of nucleotide and TA proteins from Get3 at the end of the 
targeting cycle. 
Despite rich structural information, many key questions remain regarding how the 
Get3 ATPase cycle drives the efficient delivery of TA proteins. First, even basic 
information, such as when, where and how ATP binding and hydrolysis occur in the GET 
pathway, remain elusive. Second, ADP-bound Get3 has been solved in both open and 
closed structures 13,23, raising questions as to the specificity of Get3 in recognizing 
nucleotides and generating nucleotide-driven conformational changes. Third, the 
nucleotide states of Get3 required for interacting with Get4/5 or for Get4/5-mediated 
loading of TA proteins remain controversial 4,7,25. Most importantly, models based on a 
two-state open ⇔ closed transition are insufficient to explain the complex cascade of 
protein interactions that must be coordinated by Get3, which requires multiple functional 
states in this ATPase.   
The requirement for the Sgt2•Get4/5 complex in the GET pathway raises 
additional questions. Why is Get3 unable to directly capture the TA substrate, and why is 
an upstream TA loading complex needed? How does the Get4/5 complex drive the 
transfer of TA proteins to Get3? Thus far, Get4/5 has appeared to be nothing more than a 
10 
scaffold that brings Sgt2 and Get3 into close proximity. Whether Get4/5 can actively 
regulate the conformation of Get3 to facilitate TA protein capture is unclear.  
Finally, while the predominant model for TA protein binding invokes a closed 
Get3 dimer 13 there is also evidence that Get3 can form a tetrameric complex: A small 
population of Get3 appears to be tetrameric, and recombinant Get3/TA complexes are 
predominantly tetramers on size exclusion chromatography. Further, several archaeal 
Get3 homologues form obligate tetramers 16,21. Whether and how a Get3 tetramer 
functions in TA protein targeting and how tetramerization of Get3 is coupled to its 
ATPase cycle are unclear. 
 To address these questions, here we establish a quantitative framework for the 
ATPase cycle of Saccharomyces cerevisiae (Sc) Get3. We demonstrate that Get4/5 and 
the TA protein substrate actively regulate this cycle to ensure the precise timing of ATP 
hydrolysis. These results provide an explicit model for how Get3’s ATPase cycle is 
coupled to conformational changes that drive TA protein targeting. 
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Results 
Cooperative ATP binding to Get3 active sites.  
We began by establishing a quantitative framework for the Get3 ATPase cycle 
(Fig. 1). To probe for nucleotide-driven conformational changes, we compared Get3’s 
activity under two conditions: (i) ‘Single-site’ conditions, in which Get3 is in 10–1000 
fold excess over the nucleotide so that statistically, the majority of nucleotide-bound Get3 
dimers have a single ATPase site occupied; and (ii) ‘multi-site’ conditions, in which the 
nucleotide is in excess over Get3 so that both ATPase sites are occupied. Nucleotide 
binding by Get3 is measured using both ATPase assays (Fig. 2A and Supporting 
Information (SI): Fig. S1A) and direct measurements based on changes in anisotropy of 
the fluorescent ATP analogue 2'-/3'-O-(N'-methylanthraniloyl)-ATP (mantATP; Fig. 2B). 
Under single-site conditions, Get3 binds ATP weakly and displays no discrimination 
between ATP and ADP (Fig. 2A, B; Fig. 1 & SI: Table S1, K1 & K9). In contrast, under 
‘multi-site’ conditions Get3’s ATPase reaction exhibited a cooperative dependence on 
ATP concentration, giving a Hill co-efficient of 2 and a ~10-fold higher affinity for 
binding the second ATP (Fig. 2C; Fig. 1 & SI: Table S1, K3).  
To test the specificity of this cooperative effect, we directly measured the kinetics 
of nucleotide binding and release from Get3 using: (i) environmentally sensitive changes 
in mantATP under single-site conditions (SI: Fig. S1B); and (ii) FRET between a native 
tryptophan in Get3 and mantATP under multi-site conditions (SI: Fig. S1C; 9). These 
measurements show that ATP binds two-fold faster and dissociates three-fold more 
slowly under multi-site conditions (Fig. 2D and SI: Fig. S2, black; Fig. 1 & SI: Table S1, 
k1, k-1 vs. k3, k-3), providing independent support for cooperative ATP binding to both 
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active sites of Get3. This cooperativity is specific for ATP: compared to single-site 
conditions, the rate of mantADP binding was unchanged and ADP release is over three-
fold faster under multi-site conditions (Fig. 2D and SI: Fig. S2, gold; Fig. 1 & SI: Table 
S1, k8, k-8 vs. k9, k-9), indicating that Get3 disfavors ADP occupancy at both active sites. 
Together, these results show that ATP specifically induces rearrangements in Get3 that 
lead to stronger binding of the second ATP molecule (Fig. 1, steps 1 & 3), whereas ADP 
does not.  
 
Tetramerization of Get3 activates ATP hydrolysis and is required for TA protein 
targeting  
  Unexpectedly, the observed ATPase rate constant at saturating ATP 
concentrations, or kcat, rises with increasing Get3 concentration (Figs. 2C & 3A). This 
phenomenon was observed even in the presence of BSA, an effective surfactant and 
crowding reagent, suggesting that it is unlikely to be caused by enzyme loss or 
inactivation at low concentrations. Instead, this observation suggests that an 
oligomerization process stimulates Get3’s ATPase activity.  Quantitatively, these data are 
most consistent with a model in which dimeric Get3 is in dynamic equilibrium (Kd = 3.5 
± 1.9 µM) with tetrameric Get3 that hydrolyzes ATP faster (Fig. 1, steps 4–7; SI: Eq 9). 
Analysis of the data based on this model yielded a kcat value for tetrameric Get3 of 1.3 ± 
0.4 min-1 (Fig. 1, k6), over 100-fold faster than dimeric Get3 (Fig. 3A and SI: Fig. S3A; 
Fig. 1, k4 = 0.012 min-1). This phenomenon has previously escaped detection, likely 
because it is abolished in less physiological solution conditions (SI: Fig. S3B), whereas 
our experiments were performed in the same buffer as for protein targeting/translocation 
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reactions. The transient nature of tetrameric Get3 could also render it susceptible to 
dissociation during size exclusion chromatography 26. 
  In a structure of the Methanocaldococcus jannaschii (Mj) Get3 tetramer, helix 8 
plays a key role in stabilizing the tetrameric interface. Mutations of conserved residues in 
this helix, F192D, M193D and M196D, destabilize the tetramer 16. To independently test 
whether tetramerization of ScGet3 is responsible for its ATPase activation, we mutated 
homologous residues in ScGet3 (PM199DD, ML200DD; Fig. 3B). Given their location, 
these mutations are unlikely to affect the TA binding groove in the dimer model, but 
would specifically disfavor the formation or conformation of the tetramer. These 
mutations reduced activated ATP hydrolysis at high Get3 concentrations to almost the 
same extent as the mutant ∆181-210, a negative control that lacks a large portion of the 
putative TA-binding groove (Fig. 3A, B) and completely abolished TA protein capture 
and targeting by Get3 (SI: Fig. S4D). In contrast, observed kcat values at low Get3 
concentrations, where it is primarily a dimer, were largely unchanged in these mutants 
(Fig. 3A). These results provided independent evidence that formation of a Get3 tetramer 
is required for activated ATP hydrolysis.   
  If tetramerization of Get3 and its associated ATPase activation were important, it 
would also be manifested in a TA protein targeting reaction. To test this hypothesis, we 
quantitatively measured the targeting and translocation of a TA protein, Sbh1p, to ER 
microsomal membranes (SI: Fig. S4A). An NXT glycosylation site was engineered into 
the C-terminus of Sbh1p, whose glycosylation reports on successful translocation across 
the membrane. Both the translation lysate and ER microsomes were derived from a Δget3 
yeast strain, so that the targeting of Sbh1p is dependent solely on exogenously added 
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Get3. Consistent with predictions from ATPase assays, the efficiency of Sbh1p targeting 
and translocation exhibited a cooperative dependence on Get3 concentration with a Hill 
coefficient of 2 (Fig. 3C and SI: Fig. S4B), suggesting that efficient TA protein targeting 
requires two Get3 dimers to further associate to form a tetramer. Additionally, the 
PM199DD and ML200DD mutants exhibit defects in translocation (Fig. 3D and SI: Fig. 
S4C) that quantitatively correlate with their defects in tetramerization-induced ATPase 
stimulation (Fig. 3D). Combined with the previous observation that mutants M200D and 
L201D are deficient in TA substrate binding and in supporting cell growth 13, these 
results provide strong evidence that transient formation of a Get3 tetramer is required for 
efficient TA protein targeting.  
 
Get4/5 enhances ATP binding but inhibits ATP hydrolysis by Get3. 
We next asked how the Get4/5 complex, which acts as a scaffold to facilitate TA 
protein loading from Sgt2 onto Get3, regulates the nucleotide state and ATPase activity 
of Get3. Intriguingly, Get4/5 quantitatively inhibits the ATPase activity of Get3 (Fig. 4A). 
Analysis of the ATP concentration dependence of the reaction showed that the average 
KM value is lowered to 1.4 ± 0.3 µM in the presence of Get4/5, indicating that Get3 binds 
ATP more strongly when it is bound to Get4/5 (Fig. 4B & SI: Fig. S5A). In contrast, 
Get4/5 reduced the value of kcat, indicating specific inhibition of ATP hydrolysis (Fig. 
4B). These results strongly suggest that Get4/5 induces Get3 into an alternative 
conformation in which ATP is bound more tightly but held in a catalytically 
compromised structure. 
15 
 To provide independent evidence for this model, we tested how Get4/5 alters 
nucleotide binding of Get3 using the FRET assay. The analysis showed that Get4/5 did 
not affect the rate of ATP binding to Get3 (Fig. 4C) but reduced the rate of ATP 
dissociation from Get3 at least 10-fold (Fig. 4D), providing direct evidence that Get3 
binds ATP more tightly when it is bound to Get4/5. This effect is specific for ATP, as 
under the same conditions ADP release from Get3 remained fast and was largely 
unaffected by Get4/5 (SI: Fig. S5B).   
If Get4/5 induces stronger ATP binding to Get3, then reciprocally, ATP-bound 
Get3 would bind more strongly to Get4/5. To test this prediction, we measured complex 
formation between Get3 and Get4/5 using gel filtration chromatography. With apo-Get3, 
complex assembly was not detected even at micromolar protein concentrations (SI: Fig. 
S5C). In contrast, in the presence of saturating ATP almost all the Get3 molecules formed 
a complex with Get4/5 (SI: Fig. S5D). These results, though qualitative, are consistent 
with previous pull-down experiments in which a stable Get3-4/5 complex was enriched in 
the presence of nucleotides 4,7,25. Together, these results demonstrate that Get4/5 
preferentially binds ATP-loaded Get3 and reciprocally, interaction with Get4/5 enables 
ATP to be more tightly bound to Get3. 
As the ATPase activity of Get3 is activated upon tetramerization, we further 
asked whether the Get4/5 complex inhibits this activation. With saturating Get4/5 and 
ATP, the ATPase rate constant stayed constant at 0.16 ± 0.07 min-1 and was independent 
of Get3 concentration (Fig. 4E), indicating that Get4/5 inhibits formation of the Get3 
tetramer or the ATPase activation induced by tetramerization.  
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TA protein induces rapid ATP hydrolysis and locks Get3 in the ADP-bound state 
 We next asked how the TA protein substrate regulates nucleotide binding and 
hydrolysis of Get3. To this end, we co-expressed Get3 with Sbh1p. The Get3/Sbh1 
complex purified predominantly as a tetrameric complex (SI: Fig. S6A), consistent with 
previous observations that co-expression with substrate leads to tetramerization of Get3 
16,21. 
 To determine the ATP hydrolysis rate from this complex, we carried out pre-steady-
state measurements using a high ATP concentration and Get3 active sites in 1:5 
stoichiometry relative to ATP. Under these conditions, the ATPase reaction exhibited two 
distinct kinetic phases: (i) an initial burst whose magnitude increased with increasing 
Get3 concentration (Fig. 5A & SI: Fig. S6B), representing a rapid first round of ATP 
hydrolysis; and (ii) a slower linear phase representing subsequent rounds of ATP turnover 
at steady-state. The rate constant for the first round of ATP hydrolysis is 3.3 ± 1.1 min-1 
(SI: Eq 10), over 100-fold faster than that for the Get3 dimer. The rate constant for 
subsequent, steady-state ATP turnover is 0.055 ± 0.001 min-1, 60-fold slower than the 
first turnover. Thus, loading of TA protein onto Get3 activates one round of ATP 
hydrolysis, but subsequent ATP turnover is inhibited. Further, ATPase activation in the 
Get3/TA complex was not observed under single-site conditions (Fig. 5B; cf. Fig. 2A), 
suggesting that it requires both Get3 active sites to be bound with ATP. Finally, the 
magnitude of the burst phase is stoichiometric with the concentration of Get3 active sites, 
suggesting that all four ATPs in the Get3 tetramer are hydrolyzed during the first round 
of ATP turnover. 
 To test whether nucleotide binding or release could be rate-limiting for the observed 
17 
ATPase rates, we used the fluorescence assays to directly measure these events. 
MantATP binding to the Get3/Sbh1 complex was slow and concentration-independent at 
the lowest concentrations tested under both multi-site (Fig. 5C & SI: Fig. S6C) and 
single-site conditions (SI: Fig. S6D), suggesting that a slow conformational change of the 
Get3/Sbh1 complex becomes rate-limiting for ATP binding. The rate of the dominant, 
slow phase in ATP binding is similar to that of the burst phase in the ATPase reaction 
(5.0 vs. 3.3 min-1), suggesting that the ATPase rate constant observed here may still be 
limited by a conformational change that precedes hydrolysis.  
 Nucleotide release was also significantly slowed in the Get3/Sbh1 complex. 
Remarkably, dissociation of ADP is at least 100-fold slower in this complex compared to 
free Get3 (Fig. 5D and SI: Table S2) and is indistinguishable from that of ATP or non-
hydrolyzable ATP analogues (SI: Fig. S6E and Table S2). This strongly suggests that TA 
protein loading locks Get3 into a conformation in which the ATPase sites are shielded 
from solvent and all the nucleotides are bound tightly. Nevertheless, ADP release from 
the Get3/TA complex is still 200-fold faster than the steady-state ATPase rate and is 
unaffected by the presence of up to 10 mM inorganic phosphate (SI: Fig. S6E and Table 
S2), indicating that product release is not rate-limiting for steady-state ATP turnover. 
Together, these data argue that only one round of ATP hydrolysis occurs in the GET 
pathway, after which the Get3/TA complex is locked in a catalytically inactive state 
loaded with ADP, and disassembly of this complex would be needed to reset its ATPase 
cycle. 
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Discussion: 
 
Efficient and accurate delivery of membrane proteins often requires energy input 
from nucleotide triphosphates, which in the GET pathway is harnessed and utilized by the 
Get3 ATPase 2,27. When, where, and how ATP binding and hydrolysis occur in the GET 
pathway have remained elusive. Little is known about how Get3’s nucleotide state, 
conformation and activity are regulated by its upstream and downstream effectors to 
drive TA protein targeting. Here, quantitative mechanistic analyses define a precise 
framework for Get3’s ATPase cycle and elucidate how it is used to drive this 
fundamental cellular process. 
Previous work showed that Get3’s NHD acts as a fulcrum at the dimer interface to 
generate a variety of structures including ‘open’, ‘semi-open’, ‘semi-closed’, and ‘closed’ 
states 2. The cooperative ATP binding observed here supports a model in which Get3 
changes from a largely open conformation in apo-Get3 to increasingly closed 
conformations upon successive ATP binding (Fig. 1, steps 1 & 3). Importantly, this 
cooperativity is highly specific to ATP but not ADP. Thus, an ADP-bound Get3 dimer 
remains in a largely open conformation 14,23, despite the occasional observation of 
‘closed’, ADP-bound Get3 structures 21. Nevertheless, the amount of cooperativity 
induced by ATP is fairly modest, ~10-fold. Together with published structures and 
molecular dynamics simulations 28, we speculate that Get3 exists in an ensemble of 
conformations that are in close equilibrium with one another, and each ATP binding 
event induces a modest shift in the conformational landscape. Thus, even the Get3 dimer 
bound with both ATPs is not completely ‘closed’, and is termed semi-closed here (Fig. 1). 
Intriguingly, Get3 is catalytically activated through tetramer formation (Fig. 1, steps 5, 6). 
19 
Tetramerization of Get3 was previously suggested by the structure of an MjGet3 tetramer 
and by the formation of tetrameric Get3/TA complexes 16. Our findings for the first time 
provide a function for tetrameric Get3, demonstrating that it is the active species for ATP 
hydrolysis and is crucial for efficient targeting of TA proteins. In support of this model, 
residues in helix 8 that stabilize the tetramer interface are highly conserved 14,16; their 
mutations disrupt ATPase activation and TA protein targeting by Get3 (this work) and 
lead to defects in cell viability and TA binding 13,16. Given the location of these residues, 
these phenotypes are difficult to reconcile with a dimeric model for Get3. The 
participation of these residues in the formation of an active Get3 tetramer and the 
associated ATPase activation shown here provide a cohesive model to explain this 
collection of results.   
In vivo, tetramerization of Get3 by itself should be disfavored to minimize futile 
rounds of ATP hydrolysis. This could be achieved in part by the low in vivo 
concentration of Get3, ~1 μM 29, which is below the Kd value for tetramerization (3.5 
μM). The results here further show that futile ATPase cycles of Get3 are minimized by 
the Get4/5 complex, which mediates the loading of TA proteins from Sgt2 onto Get3 4,7. 
Despite previous reports of Get4/5 binding to apo-Get3 30, our results demonstrate that 
Get4/5 preferentially binds ATP-loaded Get3 and locks it in the ATP-bound state (Fig. 6, 
step 2). This is achieved by tightening Get3’s ATP binding but inhibiting its hydrolytic 
activity, particularly the tetramerization-induced activation of ATP hydrolysis. Get4/5 
could exert these effects by inducing Get3 into a distinct, ‘occluded’ conformation in 
which its ATPase site is more closed but is incompetent for hydrolysis (Fig. 1). 
Alternatively or in addition, Get4/5 could prevent Get3’s tetramerization. The latter 
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model is particularly attractive as it explains why Get5 is a stable dimer 31: a complete 
Get4/5 complex could hold two closed Get3 dimers in the ATP-bound state, priming 
them for subsequent tetramer formation once the TA protein is loaded onto Get3 (Fig. 6, 
step 3). Regardless of the model, our data show that Get4/5 is not a passive scaffold that 
simply brings Sgt2 and Get3 into close proximity. Rather, Get4/5 actively promotes TA 
protein loading onto Get3 by locking it in the correct nucleotide state and priming its 
conformation for TA substrate capture. This also provides a rationale for why Get3 
cannot efficient capture the TA substrate by itself, and why an elaborate TA loading 
complex is required in the GET pathway4,19 . 
In contrast to Get4/5, multiple lines of evidence strongly suggest that the TA 
protein induces the tetramerization and activation of Get3’s ATPase activity (Fig. 6, step 
3): (i) co-expression of TA protein with Get3 results in a stable Get3 tetramer (this work; 
16,21); (ii) Rapid ATP hydrolysis was observed with the Get3/TA complex, as would be 
expected for an activated Get3 tetramer. Several important lessons are learned from 
analysis of the Get3/TA complex. First, after the first round of ATP hydrolysis, 
subsequent ATP turnover is 60-fold slower and incompatible with the timescale of 
protein targeting in vivo, arguing that only one round of ATP hydrolysis occurs in the 
GET pathway. Second, following ATP hydrolysis, Get3 is locked in a catalytically 
inactive state. Together with observations with the Get3•Get4/5 complex, these results 
demonstrate that the open-to-closed rearrangement of Get3 can be conceptually and 
experimentally uncoupled: even when Get3 is globally ‘closed’ and nucleotide release is 
slow, additional active site readjustments specifically regulate catalytic activity. We 
speculate that this relates to local rearrangements of the switch II loops 2, which provide 
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multiple essential catalytic residues. The ADP-bound MjGet3 tetramer structure possibly 
provides a view of a closed but catalytically inactive Get3 tetramer, in which the switch II 
loop is pulled away and incompatible for ATP hydrolysis 16. Finally, ADP release is 
significantly slowed in the Get3/TA complex and becomes indistinguishable from that of 
ATP, suggesting that the TA protein is dominant in inducing a closed Get3 tetramer.  
In the context of the targeting cycle, TA-induced Get3 tetramer formation would 
be beneficial as the hydrophobic TM of the TA substrate can be enclosed in a cage at the 
tetrameric interface and completely shielded from solvent 16, thus minimizing potential 
aggregation of the TA substrate (Fig. 6). Our results also strongly suggest that following 
hydrolysis, ADP release from the Get3/TA complex is delayed until Get3 finds the 
Get1/2 membrane receptor. Tetramer disassembly by this receptor would be needed to 
release the TA protein. As ATP- and Get1-binding to Get3 are strongly antagonistic with 
one another 7-9, the hydrolysis of ATP in the Get3/TA complex likely primes it for 
disassembly at the membrane.  
Collectively, our results lead to a new model for how the energy from ATP 
binding and hydrolysis is harnessed by Get3 to drive TA protein targeting (Fig. 6). Under 
cellular conditions, the majority of Get3 cooperatively binds ATP at both active sites, 
which induces it into a semi-closed conformation (step 1). ATP-loaded Get3 is 
preferentially captured by Get4/5, which brings Get3 into the vicinity of Sgt2 and induces 
the Get3 dimer into another conformation in which Get3 is further closed but ATP 
hydrolysis is inhibited (step 2). In this configuration, Get3 is primed to capture the TA 
substrate from Sgt2 (step 2). Loading of TA protein induces tetramerization of Get3 (step 
3), which might also drive dissociation of Get3 from Get4/5. The tetrameric Get3/TA 
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complex undergoes a rapid round of ATP hydrolysis, giving a stable ADP-loaded 
complex which then binds its receptor, Get1/2, at the ER membrane (step 4). Tetramer 
disassembly, ADP dissociation, and TA protein release into the membrane are likely 
coupled, resulting in Get1 bound to apo-Get3 in the open conformation (step 5). ATP 
binding then releases Get3 from Get1 7-9 and re-initiates the cycle.   
 Get3 is the only eukaryotic ATPase in the SIMIBI (for SRP, MinD, and BioD) 
family of deviant P-loop NTPases, including the SRP and SRP receptor (SR) that mediate 
co-translational protein targeting 32. Although the details of each system differ, the results 
here reveal many similarities in the regulatory principles between Get3 and SRP/SR. 
Both exhibit low nucleotide affinity and forego the need of external exchange factors and 
NTPase activating proteins as regulatory elements 33. Instead, both use dimeric complexes 
as the functional unit. As dimers, both undergo conformational changes on the global 
(open → closed transitions) and local (catalytic loop repositioning) scale to generate 
multiple functional states during their NTPase cycle. For both, these rearrangements 
provide key regulatory points to sense and respond to upstream and downstream 
components and effect the precise timing of nucleotide hydrolysis in the pathway. For 
example, the translating ribosome stalls GTPase activation in the SRP/SR complex 34, 
whereas Get4/5 stalls ATPase activation of Get3. Nucleotide hydrolysis is also activated 
by downstream factors in both pathways. Based on regulatory mechanisms, Get3 could 
be placed in the class of NTPases regulated by dimerization 35 whose members, aside 
from SRP and SR, also include the human GBP1, the septins, HypB, MnmE, and the 
dynamin family of GTPases 35,36. Investigation of Get3 undoubtedly enhances our 
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understanding of the mechanism, regulation, and evolution of this novel class of 
regulators.  
 
Materials and Methods 
Protein Expression and Purification.  ScGet3 was expressed and purified according to 
published procedures 14,25. Mutant Get3s were generated using Quikchange Mutagenesis 
protocol (Stratagene), and were purified identically to wildtype Get3. Purification of the 
Get4/5 and the Get3/Sbh1 complexes is described in SI: Methods.  
Fluorescence measurements. All fluorescent nucleotides were from Jena Biosciences. 
All measurements were carried out at 25 °C in Get3 assay buffer (50mM HEPES pH 7.4, 
150mM potassium acetate, 5mM magnesium acetate, 1mM DTT and 10% glycerol) using 
a Fluorolog-3-22 spectrofluorometer (Jobin Yvon) or a Kintek stopped-flow apparatus.  
Determination of the individual rate and equilibrium constants is described in SI. 
ATPase assays. All reactions were performed in Get3 assay buffer at 25 °C with [γ-32P]-
ATP (MP Biomedicals). Reactions at Get3 concentrations below 0.5 µM also included 
0.2 mg/mL BSA. Reactions were quenched in 0.75 M potassium phosphate, pH 3.3, 
analyzed by PEI cellulose thin layer chromatography (TLC) in 1 M formic acid and 0.5 
M LiCl, and quantified by autoradiography. Observed rate constants were obtained as 
described 37. Determination of individual rate and equilibrium constants in ATPase assays 
is described in SI. 
TA protein Targeting and Translocation. Yeast translation extracts were prepared as 
described in 16,38, except that an additional centrifugation step (SW55Ti, 30 min at 49,000 
rpm) was included prior to loading the clarified lysate on the G25 Superdex column. 
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Yeast microsomes were prepared as described in 6,39.  Translation and translocation of TA 
protein was carried out as described in 16 and detailed in SI. 
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Supplementary Materials and Methods 
 
Protein Expression and Purification.  Get4/5 and the Get3/Sbh1 complexes were 
expressed and purified according to previously published protocols with slight 
modifications 16,25. For Get4/5, the tetrameric fractions from MonoQ and size-exclusion 
chromatography were collected and used for all assays. For Get3/Sbh1, N-terminally 
tagged MBP-thrombin-Get3 and His6-tagged Sbh1 were purified by affinity 
chromatography using Ni-NTA, followed by the amylose resin (NEB). Proteins eluted 
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from amylose resin were treated with thrombin overnight at room temperature. The 
resulting thrombin digest was separated by size exclusion chromatography (Superdex 200, 
GE Healthcare) and the tetrameric Get3/Sbh1 fractions were collected and pooled. All 
proteins were exchanged into Get3 assay buffer in the gel filtration step.   
Fluorescence measurements. 
Equilibrium nucleotide binding under single-site conditions. Measurements were based 
on a fluorescence anisotropy readout with identical numerical processing as described 
previously  40. Samples were excited at 355 nm and fluorescence emission at 448 nm was 
monitored. For all titrations, mantATP/ADP was held constant at 0.3 μM and Get3 was 
varied as indicated. Incubation time was calculated based on the nucleotide binding rate 
under the same conditions, and varied from 5 to 10 minutes depending on Get3 
concentration.  Observed anisotropy values (Aobsd) were plotted as a function of Get3 
concentration and fit to Eq 1,  
Aobsd = A0 + (A1 ! A0 )"
[Get3]
[Get3]+Kd
   (1)   
in which A0 is the anisotropy value of free mantATP/ADP, A1 is the anisotropy when 
mant-ATP/ADP is bound to Get3, and Kd is the equilibrium dissociation constant of Get3 
for mantATP/ADP. 
 Competition of ATP with mantATP.  To test whether the mant group perturbs the 
binding affinity of ATP to Get3, 1.5 μM Get3 and either 8 or 11 μM mantATP were pre-
incubated for 10 minutes and titrated with ATP.  The observed fluorescence (Fobsd) were 
fit to Eq 2,  
   Fobsd = F0!
Ki,app
[ATP]+Ki,app
+F1 !
[ATP]
[ATP]+Ki,app 	   	    (2) 
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in which F0 is the fluorescence in the absence of the competitor, F1 is the fluorescence in 
the presence of saturating competitor, and Ki,app  is the apparent inhibition constant of 
ATP at the specified mantATP concentration, determined to be 14.2 μM at 8 μM 
mantATP and 18.5 μM at 11 μM mantATP.  These Ki,app  values are related to the true 
inhibition constant of ATP, Ki, by Eq 3,  
	   	   	   Ki,app = Ki! (1+ [mantATP]Kd )     (3) 
in which Kd is the equilibrium dissociation constant of mantATP.  The value of Ki 
determined from these experiments is 4.6 ± 0.1 µM, the same within error as the Kd value 
determined for mantATP, indicating that the mant group does not perturb the binding of 
ATP to Get3. 
 Nucleotide association and dissociation kinetics. All rate measurements were 
performed on a Kintek stopped-flow apparatus. Under single-site conditions, the 
environmental sensitivity of mantATP/ADP was used as a readout. Samples were excited 
at 355 nm and fluorescence emissions were collected at 445 nm. MantATP/ADP 
concentration was held constant at 0.3 μM and Get3 concentration was varied as 
indicated. Observed rate constants (kobsd) were plotted as a function of Get3 concentration 
and fit to Eq 4,  
kobsd = kon[Get3] + koff     (4) 
in which kon is the association rate constant, and koff is the dissociation rate constant.  
 Under multi-site conditions, FRET between a native tryptophan in Get3 and 
mantATP/ADP was used. Samples were excited at 280 nm and fluorescence emission 
was collected at 445 nm. For association rate measurements, Get3 was held constant at 
1.5 μM and mant-ATP/ADP concentration was varied as indicated. The data were fit to 
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Eq 4 above, except that the concentration of Get3 was replaced with that of 
mantATP/ADP. For dissociation rate measurements, a pulse-chase setup was used. A 
complex between Get3 and mantATP/ADP (at 30 μM) was preformed by incubation for 
10 minutes, followed by addition of unlabeled ATP•Mg2+ or ADP•Mg2+ at 2-4 mM as the 
chase to initiate mantATP/ADP dissociation. The time course for change in acceptor 
fluorescence (Fobsd) was fit to either a single (Eq. 5) or double (Eq. 6) exponential 
function, in which Fe is the fluorescence when reaction reaches equilibrium, ΔF1 and kfast 
are the magnitude and rate constant of the fluorescence change in the fast phase, and ΔF2 
and kslow are the magnitude and rate constant of the fluorescence change in the slow phase,  
Fobsd = Fe  + ΔF1 × e–kfastt                                                     (5) 
Fobsd = Fe  + ΔF1 × e–kfastt + ΔF2 × e–kslowt                                               (6) 
Eq 6 was often needed to fit kinetic data, because the time courses for 
mantATP/ADP binding or dissociation were biphasic in most cases (Figure S7). We 
cannot rule out the possibility of enzyme conformational changes or heterogeneity that 
might in part give rise to the biphasic behavior. Nevertheless, the following strongly 
suggests that this behavior is primarily caused by heterogeneity in the mant nucleotides 
(where the mant group isomerizes between the 2’- and 3’-position). (i) The relative 
magnitude of the two kinetic phases, in the absence of perturbation by enzyme, is 
~35%:65%, comparable to the equilibrium distribution of the two isomers 41. (ii) In 
single-site binding measurements, while the observed rate constants from the fast phase 
showed a linear concentration dependence expected for bi-molecular association, the rate 
constants for the slow phase are concentration independent and occur at a time scale (kslow 
~ 0.005 s-1) consistent with the time scale for conversion of one mant isomer to the other 
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42. (iii) The relative magnitudes of the two kinetic phases in binding measurements are 
unchanged by varying Get3 concentration, but the magnitude of the fast phase increases 
with increasing concentration of ATP or mantATP. This is inconsistent with enzyme 
heterogeneity giving rise to the biphasic behavior (as the faster binding enzyme 
population would sequester most of the ATP and dominate the signal if this were the 
case). Instead, these observations are expected if the faster-binding mant-isomer 
sequesters most of the enzyme and dominates the signal at higher concentrations.  Further, 
unlabeled ATP also increases the magnitude of the fast phase, suggesting that the faster-
binding isomer favors the same binding mode as that for ATP. For these reasons, and 
because the kinetics and equilibrium derived from the fast phase were in excellent 
agreement with those from direct ATPase assays, the faster-binding isomer faithfully 
reports on the nucleotide binding and release kinetics of Get3 and were used for 
determination of binding constants in this work (Figure 1 and Table S1).  
Although it is theoretically possible to remove one of the mant isomers by 
substituting 3’-OH with 3’-H, we found that this substitution itself significantly weakens 
nucleotide binding to Get3 and hence could not be used to obtain the correct rate and 
equilibrium constants.   
 
ATPase measurements. 
 Single-site, single turnover ATPase rate (k2). Get3 was in excess over a trace 
amount of ATP* (<0.1nM) and titrated at indicated concentrations.  The data were fit to 
eq 7. 
  kobsd = kcat !
[Get3]
[Get3]+KM
     (7) 
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Here, kcat is the rate constant at saturating Get3 concentration, and KM is the concentration 
of Get3 required to reach half saturation.  
 Multi-site, multiple turnover Get3 ATP hydrolysis rate.  In this assay, a fixed 
amount of Get3 was titrated with excess ATP as indicated.   The data were fit to an 
allosteric sigmoidal curve with a Hill coefficient of two (eq 8).  
  kobsd =
kcat ![ATP]2
KM2 +[ATP]2
        (8) 
Here, kcat is the rate constant at saturating Get3 concentrations, and KM2 is the product of 
ATP binding affinities for the first and second active site, i.e., KM2 = K1 !K3 .  
 ATPase activation through tetramerization of Get3. Observed kcat values were 
determined under multi-site conditions as above, at a series of Get3 concentrations. The 
plot of observed kcat as a function of Get3 concentration were fit to Eq 9,  
  observed  kcat = k6 + (k4 ! k6 )"
!K5 + K52 + 4K5[Get3]( )
2[Get3]   (9) 
where k4, k6, and K5 are defined in Figure 1.   
 ATPase rate constants in the Get3/Sbh1 complex.  Pre-steady-state measurements 
were carried out with Get3 active sites in 1:2.5 – 1:10 stoichiometry relative to saturating 
ATP (1 mM), so that both the first and subsequent ATP turnovers can be visualized.  The 
reaction time course is bi-phasic, as explained in the text, and was fit to Eq 10, 
  Fraction(ATP) = (a! b)e–kburstt ! klineart + b     (10) 
where a is the fraction of ATP before initiation of the reaction, b is the reaction end point,  
kburst is the rate constant associated with the burst phase and klinear is the rate associated 
with the slower, linear phase.   
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TA protein targeting and translocation. For translation, a model substrate (N-Sbh1p) 
was used, which contains an N-terminal flag tag, a fragment of MBP (to facilitate 
separation on SDS-PAGE) fused to yeast Sbh1p, a C-terminal bovine opsin tag for 
glycosylation, and optimized methionine content to increase signal:  
MDYKDDDDKMENAQKGEIMPNIPQMSAFWYAVRTAVINAASGRQTVDEAL 
KDAQTNSSSNNNNNNNNNNLGLVPRGSISEFGSSSPTPPGGQRTLQKRKQ 
GSSQKVAASAPKKNTNSNNSILKIYSDEATGLRVDPLVVLFLAVGFIFSV 
VALHVISKVAGKLFRMNGTEGPNMYMPMSNKTVD 
The coding sequence for this protein was cloned into a transcription plasmid 43 
under control of an SP6 promoter. mRNAs were transcribed using the SP6 Megascript kit 
(Ambion). All translation and translocation assays were carried out as described in 16. 35S-
methionine labeled pre- and glycosylated proteins were separated by 15% SDS-PAGE 
and quantified by autoradiography using a Typhoon (GE Healthcare) phosphoimager and 
Image QuantTL (GE Healthcare).  Translocation efficiency (%glycosylated protein) was 
plotted as a function of Get3 concentration and fit to Eq 11, 
    (11) 
 
in which T0 is the fraction of translocation in the absence of Get3, Tmax is the maximal  
amount of translocation with saturating Get3, Kd is the concentration of Get3 at half 
saturation, and h is the Hill co-efficient. 
 
Tobsd = To+Tmax !
[Get3]h
[Get3]h +Kdh
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TA protein capture by Get3 in translation extract. A Get3 pull-down assay in translation 
extract was performed. A 50 μl translation reaction in Δget3 lysate was initiated for 1 
minute at 26 °C, at which time His6-tagged Get3 was added. After 40 min, the reaction 
mixture was adjusted with 20 mM imidazole and 1 mM cyclohexamide (final 
concentrations), followed by the addition of 10 μl Ni-NTA beads. After incubation on a 
rotating wheel at room 25 °C for 40 minutes, the beads were washed 3 times for 5 
minutes in Get3 assay buffer with 30 mM imidazole and 0.5 mM ATP, and eluted with 
SDS-PAGE buffer containing 200 mM DTT and 300 mM imidazole. 
 
Complex formation by gel filtration: Complex formation between Get3 and Get4/5 was 
assayed using size exclusion chromatography (Superdex 200, GE Healthcare). To 
generate the complex, 13.3 µM of Get3 was incubated with 13.3 µM of Get4/5 in Get3 
assay buffer for 30 min at room temperature, with or without 200 µM ATP. Complex 
formation was assayed by following the depletion of the Get3 peak at ~14.8 ml. 
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Table S1. Summary of the rate and equilibrium constants during Get3’s ATPase cycle, 
related to Figures 1–3. The individual constants are defined in Figure 1. The values 
reported are the mean ± SD, with n = 3. 
 
Rate or equilibrium constants 
K1   12.4 ± 0.1 μM 
k1    (2.0 ± 0.1) × 105 M-1 s-1 
k-1     4.0 ± 0.3 s-1 
k2    Not determined 
K3     1.3 μM 
k3 ≥ (4.3 ± 0.4) × 105 M-1 s-1 
k-3     1.6 ± 0.1 s-1 
k4  ≥ 0.012 min-1 
K5     3.5 ± 1.9 μM 
k6     1.3 ± 0.4 min-1 
k8    (3.1 ± 0.3) × 105 M-1 s-1 
k-8   14.4 ± 0.9 s-1 
K9   11.7 ± 1.3 μM 
k9    (2.9 ± 0.2) × 105 M-1 s-1 
k-9     4.5 ± 0.6 s-1 
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Table S2. Summary of nucleotide dissociation rate constants from Get3 with and without 
effector proteins, related to Figures 4 and 5. The values reported are the mean ± SD, with 
n = 3. 
 
 
Nucleotide  
 
Effector 1
st Phase 2st Phase 
rate constant 
(s-1) 
amplitude 
(%) 
rate constant 
(s-1) 
Amplitude 
(% ) 
ATP (k-3) –   1.6 60 0.012 40 
ADP (k-8) – 14.4 56 0.015 44 
ATP  + Get4/5     0.15 40   0.0086 60 
ADP  + Get4/5 11.3 38 0.012 62 
ATP  + Sbh1     0.18    24.5 0.022   75.5 
ADP  + Sbh1     0.15    34.5 0.033   65.5 
ADP + Pi + Sbh1     0.14 39 0.036 61 
AMPPNP + Sbh1       0.214 40 0.032 60 
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Figure 2.1 Model for the ATPase cycle of Get3.  T denotes ATP, D denotes ADP. 
Different shapes depict different Get3 conformations. Steps 1–2, ATP binding and 
hydrolysis by a single active site in Get3. Step 3, ATP binding to a second active site of 
Get3. Step 4, ATP hydrolysis from dimeric Get3. Step 5, formation of the Get3 tetramer. 
Steps 6–7, ATP hydrolysis and ADP release from tetrameric Get3. Steps 8–9, release of 
ADP from the two active sites of Get3. The individual rate and equilibrium constants are 
listed in SI: Table S1. 
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Figure 2.2 Cooperative ATP binding to the two active sites of Get3. (A) Single-site ATP 
hydrolysis by Get3. The data were fit to SI: Eq 7 and gave a KM of 37 ± 6.7 µM. (B) 
Equilibrium titration of mantATP (0.3 µM, black) and mantADP (0.3 µM, gold) binding 
to Get3 under single site conditions. The data were fit to SI: Eq 1. (C) ATP hydrolysis by 
Get3 under multi-site conditions. The data were fit to SI: Eq 8 and gave a Hill coefficient 
of 2, average KM values of 3.0 ± 0.2, 3.6 ± 1.0 and 4.8 ± 0.2 µM, and observed kcat values 
of 0.26 ± 0.02, 0.33 ± 0.03 and 0.58 ± 0.03 min-1, respectively, for reactions with 0.2 
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(purple), 0.5 (blue), or 1.0 (black) µM Get3. (E) Summary of nucleotide association and 
dissociation rate constants under single and multi-site conditions. See also SI: Table S1.  
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Figure 2.3 Tetramerization stimulates Get3’s ATPase activity and is required for TA 
protein targeting. (A) Observed kcat values as a function of Get3 concentration. The data 
were fit to SI: Eq 9, which gave tetramer ATPase rate constants of 1.3 ± 0.4, 0.31±0.03, 
0.60±0.012, and 0.6±0.02 min-1, respectively, for wildtype Get3 (black) and mutants 
Δ181-210 (green), PM199DD (pink), and ML200DD (blue). (B) Structure of ScGet3 
(PDB: 3A36) highlighting the residues mutated: P199 (pink), M200 (violet), L201(blue). 
The remainder of residues 181-210 is in green. (C) Targeting and integration of Sbh1p by 
wildtype Get3. The data were fit to SI: Eq 11, which gave a K1/2 of 0.35 ± 0.029 µM and a 
Hill coefficient of 2. (D) Comparison of TA protein targeting efficiencies (open) and 
tetramer ATPase rate constants (filled) for wildtype Get3 (black) and mutants PM199DD 
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(pink), ML200DD (blue), and Δ181-210 (green). %translocation was normalized to 
wildtype Get3. 
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Figure 2.4 Get4/5 strengthens ATP binding to Get3 and inhibits its ATPase activity. (A) 
Get4/5 quantitatively inhibits the ATPase activity of Get3. Reaction contained 0.5 µM 
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Get3 and 10 µM ATP. (B) ATP concentration dependence of observed ATPase activity at 
0.5 µM Get3, in the absence (black) and presence (red) of 5 µM Get4/5. The data were fit 
to SI: Eq 8 and gave average KM values of 3.7±0.2 and 1.4 ± 0.3 µM, and kcat values of 
0.40±0.1 and 0.12±0.05 min-1 with and without Get4/5, respectively. (C) Association rate 
constants of mantATP binding to Get3 in the presence (red) and absence (black) of 3.0 
µM Get4/5. The data were fit to SI: Eq 4 and the kon values are reported in Table S1. (D) 
Dissociation of mantATP from Get3 was slowed in the presence (red) of 3.0 µM Get4/5. 
obtained koff values are reported in Table S2. (E) Observed kcat values were determined as 
a function of Get3 concentration with (red) or without (black) 50 µM Get4/5 present. The 
data with Get3 was analyzed as in (A), and the data with the Get3•Get4/5 complex were 
fit to a linear function.  
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Figure 2.5 TA protein induces rapid ATP hydrolysis. (A) Pre-steady-state ATPase 
measurement at a stoichiometry of Get3/TA:ATP of 1:5. The data were fit to SI: Eq 10 
and gave ATPase rate constants of 3.3 ± 1.1 and 0.055 ± 0.001 min-1 for the burst- and 
steady-state phase, respectively. (B) ATP hydrolysis from the Get3/TA complex under 
single-turnover conditions. The data were fit to SI: Eq 7 and gave a kcat value of 0.42 min-
1 and a KM value of 33 µM. (C) Kinetics of mantATP binding to the Get3/TA complex.  
Two phases were observed during the binding; both are invariant at 0.45 s-1 and 0.08 s-1 
over a range of mantATP concentrations. The dashed part of the curve depicts theoretical 
increases in binding rates at lower ATP concentrations where bi-molecular association is 
rate-limiting, but which was inaccessible in our experiments. (D) Dissociation of 
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mantADP from the Get3/TA complex, measured with 2 μM Get3/TA complex (green) 
and 20 μM mantADP. The data with Get3 (black) were from Figure S2F (black) and 
shown for comparison. All rate constants are reported in Table S2.  	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Figure 2.6: Model for TA protein targeting driven by the ATPase cycle of Get3, as 
described in the text.  	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Chapter 3 
 
A gradient of interaction affinities drives efficient 
targeting and recycling in the GET pathway 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A version of this chapter is currently in revision at the journal eLife (2014), was written 
by Michael E. Rome, Un Seng Chio, Harry B. Gristick Meera Rao, and, Shu-ou Shan. 
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Abstract: 
 
Efficient and accurate localization of membrane proteins requires a complex 
cascade of interactions between protein machineries. This is exemplified in the GET 
pathway, where the central targeting factor Get3 must sequentially interact with three 
distinct binding partners to ensure the delivery of Tail-Anchored (TA) proteins to the 
endoplasmic reticulum (ER) membrane. To understand the molecular principles that 
provide the vectorial driving force of these interactions, we developed quantitative 
fluorescence assays to monitor protein-protein interactions at each stage of targeting.  We 
show that nucleotide and substrate generate a gradient of interaction energies that drive 
the ordered transit of Get3 to successive effectors. These data also define how the 
targeting complex is captured, handed over, and disassembled by the ER receptor, and 
reveal a novel mechanism for how Get3 is recycled.  These results provide general 
insights into how complex protein interaction cascades are coupled to energy inputs in 
biological systems. 	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Introduction: 
Membrane proteins comprise ~30% of the proteome; their efficient and accurate 
localization is crucial for the structure and function of all cells.  Although the well-
studied co-translational Signal Recognition Particle (SRP) pathway delivers numerous 
ER-destined proteins 27, many membrane proteins utilize post-translational targeting 
pathways whose mechanisms are far less well understood.  A well-known example is tail-
anchored (TA) proteins, which comprise 3-5% of the eukaryotic membrane proteome and 
play essential roles in numerous processes including protein translocation, vesicular 
trafficking, quality control, and apoptosis 1,44-46. As their sole transmembrane domain 
(TM) is at the extreme C-terminus, TA proteins cannot engage the co-translational SRP 
machinery and instead must use post-translational pathways for localization 47.  
In the Guided Entry of Tail-anchored protein (GET) pathway, TA proteins are 
initially captured by the yeast co-chaperone Sgt2 (or mammalian SGTA)1,4. The Get4/5 
complex then enables loading of the TA substrate from Sgt2 onto Get3 (or mammalian 
TRC40), the central targeting factor 2,4,25. The Get3/TA complex binds a receptor 
complex on the ER membrane, comprised of Get1 and Get2, via which the TA protein is 
released from Get3 and inserted into the membrane 6,8,9. Dissociation from Get1/2 is then 
needed to recycle Get3 for additional rounds of targeting 7-9. Knockout of Get3 (or 
TRC40) confers stress sensitivity in yeast and embryonic lethality in mammals, 
underscoring its essential role in the proper functioning of the cell 6,10,11. 
TA protein targeting is driven by the ATPase cycle of Get3, a member of the 
SIMIBI (Signal recognition particle, MinD and BioD) class of nucleotide hydrolases 2,15. 
Crystallographic studies revealed that Get3 is an obligate homodimer in which the 
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ATPase domains bridge the dimer interface and are connected to helical domains 13,14. 
Notably, the conformation of Get3 can be tuned by its nucleotide state, the TA substrate, 
and its binding partners 3,8,9,13. Apo-Get3 is in an open conformation in which the helical 
domains are disconnected 14. ATP biases Get3 to more closed structures in which the 
helical domains form a contiguous hydrophobic surface implicated in TA protein binding 
13,14,21. The Get4/5 complex further locks Get3 into an occluded conformation, in which 
ATP is tightly bound but its hydrolysis is delayed, priming Get3 into the optimal state to 
capture the TA substrate 3,48. TA proteins induce further association of Get3 dimers to 
form a closed tetramer, which stimulates rapid ATP hydrolysis and delays ADP release 
3,16. Finally, Get1 strongly binds apo-Get3 in the open conformation (see also below), 
likely at the end of the targeting reaction 8,9,24.  
 The GET pathway demands a sequential cascade of interactions of Get3 with three 
distinct binding partners: the Get4 subunit in the Get4/5 complex and the Get1 and Get2 
subunits in the Get1/2 receptor complex. All three partners share overlapping binding sites 
on Get3 (Fig. S1 and 48). This raises intriguing questions as to the mechanisms that ensure 
the high spatial and temporal accuracy of these protein interactions. For example, Get3 
must first interact with Get4/5 in the cytosol to facilitate the loading of TA substrate 4,25. It 
is unclear what then drives the release of Get3 from Get4/5 and enables its transit to the ER 
membrane, where it interacts with the Get1/2 receptor instead.  
Similarly, how Get3 and the Get3/TA complex transit between different subunits of 
the Get1/2 receptor at the ER membrane remain unclear. Get1/2 (WRB/CAML in 
mammals) is necessary and sufficient for TA protein insertion at the ER membrane 
7,9,49,50. High-resolution crystal structures revealed that Get1 binds strongly to apo- or 
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ADP-bound Get3 in the open conformation 8,9,24. In contrast, Get2 has been co-
crystalized with Get3 in both open and closed states 8,9. In vitro reconstitution 
experiments suggest that Get2 helps bind Get3, whereas Get1 plays a more active role in 
triggering the release of TA protein from Get3 7-9. This led to the proposal that Get2 first 
captures Get3 whereas Get1 disassembles the targeting complex 1,7. However, which 
subunit is responsible for capturing the Get3/TA targeting complex has not been 
experimentally addressed, nor whether Get1 or Get2 can discriminate different substrate-
bound states of Get3. When and how Get1 and Get2 compete or collaborate to bind Get3, 
and how Get3 is transfered from one subunit to the other in the receptor complex remain 
ambiguous. It is also unclear why the receptor has two distinct proteins, both of which 
bind Get3 and are conserved throughout eukaryotic evolution. 
 At the end of targeting, Get1 is bound to apo-Get3 in a tight complex 7-9. 
Experiments with the cytosolic domain of Get1 show that its interaction with Get3 is 
strongly antagonized by ATP, leading to the current model that ATP drives the recycling 
of Get3 from the ER membrane 8,9. However, two observations raise difficulties with this 
minimal model.  In experiments with intact ER membranes or Get1/2 proteoliposomes, 
ATP is not sufficient to completely release Get3 from the membrane 7,9. Further, the tight 
interaction of Get1 with Get3 would lead to slow kinetics of their dissociation 8 that are 
incompatible with the timescale required in vivo for multiple rounds of TA protein 
targeting. 
 To address these issues, we developed fluorescence assays to report on the 
interaction of Get3 with its effectors. Quantitative measurements show that both substrate 
and nucleotide regulate the interaction of Get3 with Get4/5 and Get1/2, generating 
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differential gradients of interaction energies that drive the ordered transit of Get3 from one 
binding partner to the next. During the insertion reaction, interactions with Get1/2 are 
controlled by the substrate and nucleotide occupancy of Get3, with Get3 ‘handover’ 
occurring upon nucleotide release from the Get3/TA complex. Finally, ATP actively 
displaces Get3 from Get1, which together with Get4/5 ensure the effective recycling of 
Get3 back to the cytosol. 
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Results: 
Nucleotide and substrate govern how Get3 interacts with Get4/5 
To characterize the interaction of Get3 with full-length heterotetrameric Get4/5 25, 
we developed a sensitive fluorescence-based binding assay (Fig. 1A).  Get4 contains two 
cysteines, one of which is buried, and the other was mutated to threonine without 
affecting function. Using this ‘cyslite’ Get4/5, we detected its binding to Get3 based on a 
70% increase in the fluorescence of acrylodan-labeled Get4 at C48 (Fig. S2A). Labeled 
Get4/5 is functional in regulating Get3’s ATPase activity (Fig. S2B). This assay enables 
us to quantitatively measure the kinetics and equilibrium of Get3’s interaction with the 
Get4/5 complex, and test how their interaction is regulated in the GET pathway.  
 We and others have previously shown that Get4/5 specifically enhances ATP 
binding to Get3 3 and vice versa 7,25,48. In support of this model, equilibrium titrations 
based on the fluorescence assay show that ATP-bound Get3 binds the Get4/5 complex 
80-fold more strongly than apo-Get3 (Fig. 1B and Table 1). Interestingly, the equilibrium 
dissociation constant (Kd) for Get3-Get4/5 binding in ATP is 3.2 nM, over 40-fold tighter 
than the values obtained using a Get4/5 complex with a truncated Get5 (Get4/5N) (Table 
1 and 30,48). Thus, although Get5 is distant from the Get3-Get4 binding interface, full-
length Get5 greatly strengthens the association of Get4 with Get3. 
Once the TA substrate is loaded onto Get3, it must detach from Get4/5 and 
contact the Get1/2 receptors instead. The timing and sequence of these interactions are 
challenging to understand, given that Get4, Get2 and Get1 share overlapping binding 
sites on Get3. We asked whether the TA substrate or nucleotide state of Get3 were 
sufficient to provide the vectorial driving force for these events. We co-expressed Get3 
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with a model TA substrate, Sbh1, and purified recombinant Get3/Sbh1 complex 3,16. Our 
results show that in the ATP-bound state, the interaction with Get4/5 is weakened in the 
Get3/Sbh1 complex compared to free Get3 (Kd = 25.45 nM vs. 3.2 nM; Fig. 1C, D and 
Table 1A). Remarkably, no interaction could be detected between Get4/5 and the apo-
Get3/Sbh1 complex (Fig. 1C, D and Table 1A). Thus, the combination of substrate 
loading and nucleotide release drive the dissociation of Get3 from Get4/5. 
Given the extremely tight interaction of Get3 with Get4/5 in ATP, the question 
arises as to how Get3 samples various Sgt2•Get4/5 complexes for the presence of the TA 
substrate. Kinetic measurements show that Get3-Get4/5 association in ATP is 
extraordinarily fast and at the diffusion-limit of macromolecular interactions (~108 M-1s-1; 
Fig. 2A and B; Table 1B). Further, the association kinetics exhibits a strong dependence 
on ionic strength (Fig. 2C and Table 1B), demonstrating that the rapid initial Get3-Get4/5 
association is in part driven by electrostatic attractions. Although all the rate 
measurements showed two kinetic phases (Fig. 2 and S2; Table 1B & C), the difference 
between the two phases is modest (≤10-fold in rates and ≤2-fold in equilibrium) and does 
not affect the conclusions herein. Interestingly, dissociation of the complex is also fast 
(Fig. 2D and Table 1C), indicating that the Get3•Get4/5 complex is highly dynamic. 
Collectively, these results show that in the ATP-bound state, the interaction of 
Get3 with Get4/5 is tight yet highly dynamic, allowing Get3 to sample multiple Get4/5 
complexes on a short timescale. Further, TA substrate loading and nucleotide release 
collectively drive the dissociation of Get3 from Get4/5, enabling the transit of the 
targeting complex to the ER membrane.   
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Capture and handover of Get3/TA by the Get1/2 receptor  
 To test how the Get3 targeting cycle is completed at the ER membrane, we began 
by examining the cytosolic domains of Get1 and Get2 (Get1-CD and Get2-CD, 
respectively), both of which bind Get3 via overlapping sites (Fig. S1; 8,9). To directly 
measure the interaction of Get3 with Get1-CD and Get2-CD, we developed a 
fluorescence-based assay. Both Get1 and Get2 are cysteineless, in which engineered 
single cysteines were introduced for fluorescence labeling. We monitored the binding of 
Get3 to Get1-CD or Get2-CD based on robust increases in the fluorescence anisotropy of 
fluorescein labeled at Get1(C62) or Get2(C34) (Fig. 3A). In addition, Get3 binding 
strongly enhances the fluorescence of Coumarin-labeled Get1(C62) (Fig. S3A), providing 
an independent assay to measure the Get3-Get1-CD interaction. The cysteine mutants of 
Get1-CD and Get2-CD are functional in binding Get3 (Fig. S3B and data not shown). 
Using these assays, we tested how the interactions of Get3 with Get1 and Get2 are 
regulated during targeting.  
 The equilibrium binding affinities of Get3 for Get1-CD and Get2-CD were 
determined as a function of the substrate- and nucleotide-bound state of Get3 (Fig. 3, B & 
C), and summarized in the order by which the Get3/TA complex proceeds through its 
ATPase cycle during the targeting reaction (Fig. 4A and Table 2).  Prior to nucleotide 
release, Get2 has a much higher affinity for the Get3/TA complex than for Get1, 
suggesting that Get2 is responsible for initial capture of the targeting complex (Fig. 4A, 
Get3/TA complex). Whereas the Get2-Get3 interaction is relatively insensitive to the 
nucleotide state and substrate binding of Get3, Get1 strongly prefers to bind free, apo-
Get3 such that in this state, Get3 has a 10-fold higher affinity for Get1 than Get2 (Fig. 4A, 
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red vs purple bars).  Thus, nucleotide- and substrate-induced conformational changes 
allow Get3 to sequentially interact with Get2 and then Get1 at the membrane.  
Interestingly, once ADP is released, Get1-CD binds the Get3/TA complex with an 
affinity similar to that of Get2-CD (Fig. 4A, apo-Get3/TA; Table 2). This strongly 
suggests that nucleotide release is a key event upon which the targeting complex initiates 
contact with Get1. In addition, it suggests that the Get2 and Get1 subunits of the receptor 
complex cooperate in binding Get3/TA at this stage. To test this model, we utilized a 
Get1/2-mini construct 7, in which Get1-CD and Get2-CD are fused to a pair of oppositely 
charged α-helices that stably dimerize (Fig. 4B cartoon, and Fig. S4). If the Get1 and 
Get2 subunits cooperate in binding the Get3/TA complex, then mini-Get1/2 will bind 
Get3/TA more strongly than either Get1-CD or Get2-CD. Indeed, mini-Get1/2 labeled 
with DACM at Get1(C62) bound the Get3/TA complex ~6 fold more tightly than Get1-
CD or Get2-CD (Fig. 4B, closed circle, Fig. S4B, and Table 2). As a control, a mini-
Get1/2 containing a mutant Get2 defective in Get3 binding (mini-Get1/2RERR, 7) yielded 
a binding constant identical to Get1-CD (Fig. 4B, open circles; Table 2), confirming the 
contribution of Get2 to Get3/TA binding in the fusion protein. These results suggest that 
once ADP is released from the Get3/TA complex, both subunits in the Get1/2 receptor 
bind the targeting complex synergistically. This not only enhances the efficiency of 
capture, but could also provide a productive mechanism for the Get3/TA complex to be 
transferred from the Get2 to Get1 subunit.  
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Get3 interactions with the full-length receptor in proteoliposomes 
To test the insights from measurements with Get1-CD and Get2-CD in the context 
of the full-length proteins in the membrane environment, we expressed and purified full-
length Get1 and Get2 and incorporated them either individually or together into 
proteoliposomes (PL) (Fig. S5). Using a semi-quantitative proteoliposome sedimentation 
assay (Fig. 5A), we varied the nucleotide and substrate occupancy of Get3 and measured 
the amount of Get3 bound to either Get1- or Get2-PL (Fig. 5B). In general, we found that 
Get3 binds to Get1-PL and Get2-PL at much lower concentrations than what was needed 
for binding Get1-CD and Get2-CD, suggesting that the transmembrane domain of Get1/2 
and/or the presence of the phospholipid membrane enhances the interaction of Get3 with 
its membrane receptors. 
In agreement with results obtained with the cytosolic domains, Get2-PL 
indiscriminately bound to Get3 with modest sensitivity to the nucleotide state or the 
presence of TA substrate (Fig. 5B). Get1-PL bound most strongly to apo-Get3; the 
interaction is weaker with the Get3/TA complex in the apo-state, and is completely 
abolished if Get3/TA is loaded with ATP (Fig. 5C). Surprisingly, although ATP is 
expected to completely antagonize Get1 binding to Get3 based on the results with Get1-
CD (7-9 and the results above), significant albeit weakened binding of Get3 to Get1-PL 
was observed in the presence of ATP (Fig. 5). In summary, binding of Get3 to full-length 
Get1 and Get2 in the membrane qualitatively recapitulates the trends observed with Get1-
CD and Get2-CD, with one notable exception for Get1 interaction with ATP-bound Get3. 
 
ATP actively displaces Get3 from Get1 
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At the end of the targeting reaction, Get3 is locked into a tight complex with Get1 
(7-9 and Fig. 4). It has been reported that Get1 and ATP compete with one another for 
binding Get3 8,9, which we also observed in our fluorescence assays (Fig. 4A). However, 
available data only support the role of ATP as a competitor that prevents Get3 re-binding 
to Get1-CD. Whether ATP actively displaces Get3 from the ER membrane is unclear. To 
test this hypothesis, we compared the kinetics of Get3 dissociation from Get1-CD driven 
either by ATP, or by unlabeled Get1 that simply traps spontaneously dissociated Get3 
(Fig. 6A cartoon). We found that the Get3•Get1-CD complex is kinetically stable, with a 
lifetime exceeding 200 s (Fig. 6A, black). Remarkably, ATP accelerates the release of 
Get3 from Get1-CD at least 30-fold, reducing the lifetime of the complex to <5 sec (Fig. 
6A, orange; Table 2).  This demonstrates that ATP does not act as a passive trap, but 
rather actively displaces Get3 from Get1. 
Independent evidence for an active displacement mechanism was obtained by 
monitoring the reciprocal reaction, release of mant-ATP from Get3 3. To test whether 
Get1 actively displaces ATP from Get3, we compared the kinetics of mant-ATP release 
from Get3 driven either by Get1-CD, or by unlabeled ATP that simply traps 
spontaneously released Get3 (Fig. 6B cartoon). The data show that reciprocally, Get1 
accelerates ATP release from Get3 >30-fold (Fig. 6B). Together, these results 
demonstrate a highly active disassembly process in which Get1 and ATP ‘push’ each 
other from Get3.  
 
 
Get4/5 is required for recycling Get3 from the ER membrane 
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The tight binding of Get3 to full-length Get1/2 at the ER membrane poses a 
fundamental challenge for TA trafficking: how is Get3 effectively recycled back to the 
cytosol for additional rounds of TA targeting? Although ATP can displace Get3 from 
Get1, our results with Get1-PL indicate that ATP alone is insufficient to drive the 
complete release of Get3 from the full-length receptor at the membrane (Fig. 5). To 
address this problem, we pre-incubated Get3 with Get1-PL and tested which combination 
of factors is required for complete removal of Get3 from Get1 (Fig. 7A cartoon). Given 
the high affinity of Get4/5 for ATP-bound Get3 (Kd = 3.2 nM, Fig. 1), we suspected that 
both ATP and Get4/5 would be required to partition Get3 back to the cytosol. Although 
super physiological levels of ATP could remove a substantial fraction of Get3 from Get1-
PL, we found that a combination of ATP and Get4/5 at physiological concentrations were 
able to completely displace Get3 from Get1-PL (Fig. 7A). Similar results were obtained 
with yeast ER microsomes derived from a Get3 deletion strain (Δget3 yRM): the 
combination of ATP and Get4/5 are necessary and sufficient for complete removal of 
Get3 from the ER membrane, whereas either component alone is not (Fig. 7B). Together, 
these results strongly suggest that Get4/5 is needed to efficiently recycle Get3 from the 
ER membrane at the end of TA targeting. Consistent with an additional role for Get4/5 in 
the GET pathway beyond mediating TA substrate transfer from Sgt2 to Get3, an in vivo 
assay based on Kar2p secretion 6 showed that Δget4 causes a much stronger defect in TA 
protein biogenesis than Δsgt2 (Fig. S6). 
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Discussion:  
The GET pathway demands a complex cascade of substrate capture, loading, 
delivery, release, and insertion events, whose underlying molecular basis remains 
enigmatic.  This process requires the highly ordered interaction of Get3 with distinct 
partners that contact Get3 at overlapping binding sites (Fig. S1 and 48), raising intriguing 
questions as to how the correct sequence and timing of these molecular interactions is 
ensured.  In this work, quantitative analyses using fluorescence and biochemical assays 
resolve these questions, provide more detailed models for the targeting and insertion of 
TA proteins at the membrane, and suggest a new role for Get4/5 in the recycling of Get3 
from the membrane. 
 
Get4/5 samples and discriminates different Get3 states. 
 The Get4/5 complex is required for Get-dependent TA targeting and facilitates the 
transfer of TA proteins from Sgt2 to Get3 4. Remarkably, association between Get3 and 
Get4/5 occurs at diffusion-limited rates (Fig. 2) and is among the fastest association rates 
observed between proteins. This is achieved in part by electrostatic attractions, a 
recurring theme that has also been observed with the barnase-barstar interaction 51, 
ubiquitin ligases binding to ubiquitin-conjugating enzymes 52, and ribosomal binding 
proteins 53. This allows Get3 to form a tight complex with Get4/5, while still being able 
to sample multiple Get4/5 complexes on a short timescale until it finds its cognate TA 
substrate. Notably, the TA-binding chaperone Sgt2 also binds the Get4/5 complex with 
rapid association and dissociation rates 54. These examples likely underlie a common 
58 
principle whereby factors involved in membrane protein biogenesis continuously sample 
their environments. 
 Get4/5 displays an exceptional ability to discriminate between distinct nucleotide 
and substrate states of Get3. ATP binding to Get3 enhances the interaction with Get4/5 
80-fold, whereas TA substrate occupancy weakens this interaction 8-fold, and nucleotide 
release from the Get3/TA complex abolishes the interaction. This enables Get4/5 to 
strongly bind and pre-organize Get3 in the correct nucleotide and conformational state to 
capture the TA substrate, but also to detach readily from Get3 once the TA substrate is 
loaded. The latter also implies that Get3 transits to the ER membrane to interact with the 
Get1/2 receptor only when it acquires its TA substrate. How Get4/5 generates this 
exquisite molecular discrimination awaits to be determined. 
  
Differential interactions with Get1 and Get2 drive the capture and remodeling of the 
targeting complex. 
 The mechanism of TA protein insertion at the ER membrane remains enigmatic 
with several outstanding questions: 1) Why are two ER membrane proteins, Get1 and 
Get2, required? 2) When do Get1 and Get2 interact with the targeting complex, and how 
is this decision made? 3) How is Get3 recycled from the ER membrane at the end of the 
targeting cycle?  Quantitative analysis of Get3’s interaction with Get1/2 shed new light 
on these issues. 
 We previously showed that ADP release from the Get3/TA complex is 100-fold 
slower than free Get3, and ATP-rebinding to the Get3/TA complex is delayed >10,000-
fold compared to free Get3 3. This suggests that Get3/TA complexes encounter the 
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Get1/2 receptor in the ADP state. In this work, we found that Get2 binds with little 
discrimination as to the nucleotide or substrate occupancy of Get3. In contrast, Get1 has a 
much lower affinity for the Get3/TA complex before nucleotide release and instead 
strongly prefers apo-, free Get3.  Coupled with the tight binding of Get3/TA to Get2-PL, 
this provides energetic evidence that Get2 is the first subunit to capture the Get3/TA 
targeting complex in the ADP-bound state (Fig. 8A, step 2).  On the other hand, Get1 acts 
only at late stages, and its stronger binding to free Get3 compared to Get3/TA provides 
the driving force for the disassembly of the Get3/TA complex. This model is consistent 
with experiments showing that high concentrations of Get1 can trigger substrate release 
from Get3 9. 
Interestingly, nucleotide release from the Get3/TA complex induces distinct 
changes in the interaction of Get3 with multiple partners. Upon ADP release, the 
interaction of Get4/5 with Get3/TA is completely abolished, whereas Get1 attains 
substantial affinity for Get3/TA. Further, the anisotropy values of both the Get1•Get3/TA 
and Get2•Get3/TA complexes increase substantially when ADP dissociates (Fig. S3C). 
These results strongly suggest that the Get3/TA complex transitions to a new 
conformational state after ADP release, which we term a ‘strained tetramer’ (Fig. 8A, 
step 2). At this stage, the affinities of Get1 and Get2 for the Get3/TA complex become 
approximately equal. Coupled with the strong preference of Get1 for apo-Get3, we 
propose that ADP-release represents a key switch point at which Get3 is transferred from 
Get2 to Get1 to initiate remodeling and disassembly of the Get3/TA complex (Fig. 8A, 
steps 2-3). 
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 Experiments in which Get1 and Get2 are simultaneously presented to Get3 (Fig. 
4B) further demonstrate that both subunits co-bind once the Get3/TA complex reaches 
the apo-stage (strained tetramer conformation). Co-binding provides a productive 
pathway that minimizes loss of the Get3/TA complex during its transfer from Get2 to 
Get1 at the membrane. It also raises the possibility that Get2 can help retain any Get3/TA 
complexes that fail to be successfully disassembled by Get1 and allow for additional 
rounds of remodeling, thus enhancing the efficiency of this process. 
 
ATP and Get4/5 cooperate in the recycling of Get3 from the membrane. 
  Once the TA substrate is inserted into the membrane, Get3 must partition back to 
the cytosol to begin a new round of protein targeting.  Our pre-steady state kinetic 
analysis shows that dissociation of Get1 from Get3 is very slow and poses a kinetic 
barrier for multiple rounds of targeting in vivo. Although previous work showed that ATP 
strongly antagonizes the binding of Get1-CD to Get3 1,7,8, whether ATP passively traps 
free Get3 or actively disassembles the Get3•Get1 complex was unclear. Here we provide 
strong evidence that ATP actively displaces Get3 from Get1 and brings the kinetics of 
Get3 recycling to a much faster timescale. This result also implies the existence of a 
transient Get3•Get1•ATP intermediate during disassembly, in which ATP and Get1 ‘push’ 
one another to accelerate release (Fig. 8B, steps 4-5).   
 Which factor wins this ‘tug of war’ depends both on their respective affinities for 
Get3 and concentrations in cells. With Get1-CD, the cellular concentration of ATP (4 
mM) is sufficient to drive the unidirectional release of Get3 from Get1. However, binding 
assays with full-length Get1/2 in proteoliposomes or ER-microsomes indicate that 
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additional factors are needed. Full-length Get1 binds to Get3 much more tightly than 
Get1-CD, such that complete Get3 dissociation cannot be achieved even at super 
physiological concentrations of ATP. These results are consistent with previous 
observations that Get3 could only be competed off Get1/2-PL or ER microsomes under 
conditions when ATP and excess Get3 competitor were used 7, or when Get1PL-Get3 
complexes are subjected to rapid pull-downs in the presence of ATP 9.  
 The finding that both Get4/5 and ATP are required for Get3 ER recycling (Fig. 7) 
resolves the conundrum for how the pathway overcomes the tight binding of Get3 to Get1 
to achieve effective recycling. These results reveal that Get4/5 is required for maintaining 
a cytosolic pool of Get3, and explain why deletion of Get4/5 lead to phenotypes more 
similar to that of Δget3 rather than Δsgt2 cells 4,11. If the sole function of Get4/5 is to 
facilitate TA transfer from Sgt2 to Get3, then deletion of Get4/5 should phenocopy that 
of Sgt2. Instead, Δget4/5 mutations are significantly more deleterious than Δsgt2, 
supporting the role of Get4/5 as an essential factor in controlling the cellular localization 
of Get3 (Fig. S6 and 4,55).  
 Taken together, our results provide a new model for how Get3/TA complexes are 
captured, processed, and recycled at the ER membrane (Fig. 8A). Get3/TA complexes 
transit to the ER in the ADP state and are first tethered to the membrane by binding Get2 
(step 1). ADP release induces a strained conformation in the Get3/TA tetramer, allowing 
the complex to be transferred from Get2 to Get1 in a coordinated mechanism (step 2-3). 
The strong preference of Get1 for apo-Get3 over Get3/TA and its ability to insert into the 
hydrophobic cavity of Get3 8,9,24 drive the disassembly of the targeting complex (step 3). 
After TA insertion, ATP binding to the Get1•Get3 complex produces a highly unstable 
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intermediate, leading to facile displacement of Get3 from the membrane (step 4-5). Once 
Get3•ATP complexes dissociate from Get1, they rapidly form a tight complex with 
Get4/5, preventing re-binding of Get3 to Get1 (step 5). The protein targeting cycle then 
resets as Get3 waits to bind a new TA substrate (step 6). 
 Collectively, the results herein demonstrate that the TA substrate and nucleotide 
generate differential gradients of interaction affinities between Get3 and its binding 
partners (Fig. 8B), providing the vectorial driving force for the ordered capture, 
remodeling and disassembly of the targeting complex during TA protein targeting. These 
results also rationalize why two distinct subunits are required in the Get1/2 receptor: it 
resolves the conflicting requirement of the membrane receptor to both effectively capture 
and destabilize the targeting complex, by using Get1 and Get2 to fulfill these two 
opposite functions. Effectively, Get2 bridges the gap during Get3’s interaction cycle, 
after Get3/TA dissociates from Get4 and before it can interact effectively with Get1 (Fig. 
8B). This principle shares conceptual parallels to the machineries mediating vesicular 
tethering and fusion 56,57. Analogous to the role of Rabs in tethering nascent vesicles to 
target organelles, Get2 acts to capture and tether Get3/TA complexes to the ER 
membrane. Analogous to the role of v-/t-SNAREs as remodeling machines that 
destabilize membrane bilayers and induce fusion 58,59, Get1 acts to remodel and 
disassemble the targeting complex to enable membrane insertion of the TA substrate.  
Such ‘two-component’ systems may be a general strategy during protein targeting 
processes. 
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Materials and Methods 
 
Protein Expression and Purification.  ScGet3, ScGet3/TA, and ScGet4/5 were expressed 
and purified according to published procedures 3,14,16,25. All mutant proteins were 
generated using Quikchange Mutagenesis protocol (Stratagene), and were purified 
identically to the wildtype protein. His6-tagged Get1-CD and Get2-CD (both in a pET33b 
expression vector) were induced at log phase for 3 hours at 37°C with 0.8mM Isopropyl 
β-D-1-thiogalactopyranoside (IPTG). Overexpressed protein in clarified lysate was 
purified by Ni-NTA affinity chromatography followed by thrombin digestion to remove 
the affinity tag. Get2-CD was further purified by gel filtration chromatography on a 
Superdex200 column (GE healthcare). Get1-CD was further purified by gel filtration 
chromatography on a superpose 12 column (GE healthcare). His6-tag Get1/2-mini 7 was 
expressed for 3 hours at 37°C, and purified by Ni-NTA affinity chromatography. To 
obtain stoichiometric complex, partially purified proteins were further purified with a 
125ml Superdex75 gel filtration column (GE healthcare). Full-length Get1 and Get2 were 
expressed identically to 9 using the overnight auto induction system (Novagen) in TB 
media 60. For purification, Get1 and Get2 (approximately 20-30 g of dry weight cell 
pellet) were re-suspended in buffer A (50 mM HEPES, pH 8.0, 500 mM NaCl, 10% 
Glycerol) containing protease inhibitor cocktail (Roche), and lysed by French cell press. 
Unbroken cells were removed by centrifugation at 12000g for 20 minutes, and the 
supernatant was subjected to ultracentrifugation in a Ti45 at 200,000 x g for 50 minutes. 
The resulting membrane pellet was washed in buffer A, resuspended in buffer A with 
0.5% LDAO and 20mM Imidazole using a dounce homogenizer, and incubated for 1 
hour under gentle agitation. Detergent-solubilized membrane was clarified by 
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ultracentrifugation in a Ti45 as above, and the supernatant was subjected to Ni-NTA 
chromatography in buffer A with 0.1% LDAO and 20 mM Imidazole. Following 
extensive washing, His6-tagged Get1 or Get2 was eluted in buffer A with 0.1% LDAO 
and 200 mM Imidazole, and immediately flash frozen in liquid nitrogen. All proteins 
(with the exception of Get1/2 full-length) were exchanged into Get3 assay buffer (50mM 
HEPES pH 7.4, 150mM potassium acetate, 5mM magnesium acetate, 1mM DTT and 
10% glycerol) in the gel filtration step. 
 
Fluorescence labeling.  Get4/5 (C177T/S48C) was labeled with thiol-reactive acrylodan. 
Get1CD-Q62C, Get2CD-T34C, and Get1/2 mini (with a Get1 Q62C mutation) were 
labeled with maleimide derivatives of either coumarin (DACM) or fluorescein. Protein 
was dialyzed in labeling buffer (50 mM KHepes, pH 7.0, 300 mM NaCl) and treated with 
2 mM TCEP to reduce the disulfide bonds. The labeling reaction was carried out using a 
10-30 fold excess of dye over protein. The reaction was incubated overnight at 4 °C and 
stopped by adding 2 mM DTT. Excess dye was removed by gel filtration using Sephadex 
G-25 (Sigma) 43. 
 
Fluorescence measurements 
All measurements were carried out at 25 °C in Get3 assay buffer using a 
Fluorolog-3-22 spectrofluorometer (Jobin Yvon) or a Kintek stopped-flow apparatus.   
 Get4/5 equilibrium measurements. Measurements using acrylodan-labeled Get4/5 
were based on an environmental sensitive readout. Samples were excited at 370 nm and 
fluorescence emission at 490 nm was monitored. For all titrations, Get4/5FL was held 
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constant (50 – 200 nM) and Get3 concentration was varied. Incubation time was 10 
minutes and nucleotide was present at 2 mM wherever applicable. Observed fluorescence 
values (Fobsd) were plotted as a function of Get3 concentration and fit to Eq 1, 
	   Fobsd = F0 +F1 ! Kd +[Get4/5]+[Get3]" (Kd +[Get3]+[Get4/5])2 " 4[Get3][Get4/5]2[Get4/5] 	   (1) 
in which Fobsd is the observed fluorescence, Fo is the initial fluorescence value, F1 is the 
maximum fluorescence change at saturating Get3 concentrations, and Kd is the 
equilibrium dissociation constant of the complex.  
 Get4/5 association and dissociation kinetics. All rate measurements were 
performed on a Kintek stopped-flow apparatus. For association rate measurements, 
acrylodan-labeled Get4/5 was held constant at 0.2 μM, Get3 concentration was varied as 
indicated, and ATP was present at 2 mM. Observed rate constants (kobsd) were plotted as a 
function of Get3 concentration and fit to Eq 2,  
kobsd = kon[Get3] + koff     (2) 
in which kon is the association rate constant, and koff is the dissociation rate constant.  
 For dissociation rate measurements, a pulse-chase experiment was used. A 
complex between acrylodan-labeled Get4/5 (at 0.15 μM) and Get3 (at 0.3 μM) was 
preformed by incubation in 2 mM ATP for 10 minutes, followed by addition of unlabeled 
Get4/5 at 6 μM as the chase to initiate Get3-Get4/5 dissociation. The time course for 
change in fluorescence (Fobsd) was fit to a double exponential function (Eq. 3),  
Fobsd = Fe  + ΔF1 × e–kfastt + ΔF2 × e–kslowt                                               (3) 
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in which Fe is the fluorescence when the reaction reaches equilibrium, ΔF1 and kfast are the 
magnitude and rate constant of the fluorescence change in the fast phase, and ΔF2 and 
kslow are the magnitude and rate constant of the fluorescence change in the slow phase,  
 
 Equilibrium measurements of Get3 binding to Get1- and Get2-CD. Measurements 
using fluorescein-labeled Get1- or Get2-CD were based on a fluorescence anisotropy 
readout (Fig. 3). Samples were excited at 450 nm and fluorescence emission at 518 nm 
was monitored. For all titrations, Get1-CD or Get2-CD was held constant at 200 nM and 
Get3 or Get3/TA concentration was varied. Incubation time was 5-10 minutes depending 
on protein concentration, and nucleotide was present at 2mM. Observed anisotropy 
values were plotted as a function of Get3 concentration and fit to Eq 1, with anisotropy 
values replacing the fluorescence values. 
 Equilibrium measurements of Get3/TA binding to Get1/2-mini. Measurements are 
based on the fluorescence change of DACM-labeled Get1 (denoted by *) in Get1*/2-mini. 
Samples were excited at 380 nm and fluorescence emission at 470 nm was monitored. 
For all titrations, Get1*/2-mini was held constant at 200 nM and Get3/TA concentration 
was varied. Incubation time was 10 minutes. Observed fluorescence values (Fobsd) were 
plotted as a function of Get3/TA concentration and fit to Eq 1. 
 Get1-CD dissociation kinetics from Get3.  Measurements used a pulse-chase 
setup on the stopped-flow apparatus (Kintek). 150 nM DACM-labeled Get1-CD was pre-
incubated with 350 nM Get3 for 15 minutes, and chased by addition of either 2 mM ATP  
or 8.5µM unlabeled Get1-CD to initiate complex dissociation. Samples were excited at 
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380 nm and fluorescence emission at 470 nm was monitored. The time course for change 
in fluorescence (Fobsd) was fit to Eq. 3.  
Kinetics of mant-ATP dissociation from Get3.  Measurements are based on FRET 
between mant-ATP and a native tryptophan in Get3 3, using a pulse-chase setup on a 
stopped-flow apparatus (Kintek). A complex between mant-ATP (at 15 μM) and Get3 
(1.5 μM) was preformed by incubation for 20 minutes, followed by addition of either 
Get1 (at 2.5 μM) or excess ATP (2 mM) to initiate complex dissociation. The time course 
for change in donor (mant-ATP) fluorescence (Fobsd) was fit to Eq. 3.  
 
Reconstitution of Get1/2 into proteoliposomes.  Proteoliposomes containing Get1, Get2, 
or the Get1/2 complex were prepared as previously described 9 with modifications. The 
following mixture was assembled in a volume of 300-400 μl: 2-3 μM of membrane 
protein, 87 mg of washed biobeads (SM-2, Bio-Rad), 30 μl of 20 mg/ml lipids (4:1 
PC:PE), 300 μl of reconstitution buffer (50 mM HEPES-KOH, pH 7.4, 500 mM 
potassium acetate, 5 mM magnesium acetate, 250 mM sucrose, 1 mM DTT, 0.25% DBC). 
The mixture was incubated overnight with gentle agitation at 4 °C. For Get2-only 
proteoliposomes, half the amount of biobeads was added for the overnight incubation and 
a second incubation was included with 87 more mg of biobeads for 2 hours. Following 
biobead removal, 5 volumes of cold water was added to the reaction, and then pelleted at 
311,000g for 30 minutes. The resulting proteoliposome-containing pellet was 
resuspended in 70 μl of membrane buffer (50 mM HEPES-KOH pH 7.4, 100 mM 
potassium acetate, 5 mM magnesium acetate, 250 mM sucrose, and 1 mM DTT). 
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Proteoliposome concentration was determined by SDS-PAGE with a known amount of 
recombinant Get1 or Get2 protein using silver stain (Thermo). 
 
Proteoliposome sedimentation assay.  The experiments described in Figure 5 were 
performed using the following setup. For Get2-PL binding assays, 96 nM of Get2-PL or 
equivalent volume of empty-PL were mixed with 500 nM Get3 or Get3/TA in Get3 assay 
buffer and 2 mM ATP (optional), in a total volume of 150 μl. For Get1-PL binding assays, 
20 nM of Get1-PL or equivalent volume of empty-PL were mixed with 40 nM Get3 or 
Get3/TA Get3 assay buffer and 2 mM ATP (optional), in a total volume of 150 μl. The 
reactions were incubated for 10 minutes at room temperature, and then ultracentrifuged at 
434,000g for 30 minutes. The resulting pellet was resuspended in gel loading dye, and 
analyzed by SDS-PAGE and silver-staining. The protein bands were quantified using 
Image QuantTL (GE Healthcare). All values were normalized to the strongest binder in 
each data set (i.e., ATP-Get3 for Get2-PL, and apo-Get3 for Get1-PL). When comparing 
Get3 to Get3/TA binding, the values obtained for Get3/TA were multiplied by 1/2 to 
account for the fact that Get3/TA is a tetramer whereas Get3 is a dimeric. 
 
Get3 recycling assay.  Experiments using Get1-PL (Figure 6C) were initiated by pre-
incubating the following mixture for 10 minutes at room temperature: 100 nM of Get1-
PL or equivalent volume of empty-PL, 100 nM His6-Get3, and ATP (at indicated 
concentrations) in a total volume of 150 μl in Get3 assay buffer. Get4/5 (at indicated 
concentrations) was then added for an additional 10 minutes and the reaction was pelleted 
as described for the sedimentation assay. Get3 was detected by Western blotting using an 
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anti-His antibody (Qiagen). Experiments with yRM were initiated by pre-incubating the 
following mixture for 10 minutes at room temperature: 0.26 U/mL of Δget3 yRM, 50 nM 
His6-Get3, and ATP (at indicated concentrations) in a total volume of 150 μl in Get3 
assay buffer. Get4/5 (at indicated concentrations) was then added for an additional 10 
minutes and the reaction was pelleted as described for the sedimentation assay.  
Equivalent amounts of the soluble and pellet fractions were analyzed by western blot 
against His6.  
Kar2 secretion assay.  Kar2 secretion assays were carried out as described in 6. For 
western blot analysis, Kar2 anti-rabbit antibody was used at 1/3000 dilution. The protein 
bands were quantified using Image QuantTL (GE Healthcare).   
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Table 1 Summary of the equilibrium binding affinities and kinetics of Get3’s 
interaction with Get45.	  
 
A. Equilibrium affinity of the interaction of Get3 with Get4/5. 
Get4/5 
construct 
Get3 
complex Nucleotide Kd (nM) 
Full-length 
Get4/5 
Get3 
Apo 233.5 ± 47.3 
ATP 3.20 ± 1.97 
Get3/TA 
Apo Not detectable 
ATP 25.5 ± 4.31 
ADP 19.32 ± 1.37 
Get4/5N Get3 
Apo 6.0 × 103 
ATP 127 ± 5.6 
 
B. Summary of the kinetics of Get3-Get4/5 association in ATP.  
Ionic 
Strength 
Buffer 
1st Phase 2st Phase 
k1 (µM-1 s-1) 
amplitude 
(%) k2 (µM
-1 s-1) amplitude (% ) 
150 mM 
KOAc 143.8 ± 11.5 57 43.5 ± 5.0 43 
350 mM 
NaCl 8.9 ± 0.419 64 32.9 ± 6.28 36 
100 mM 
NaCl 145.3 ± 5.88 59 39.2 ± 4.05 41 
No 
Salt 271.9 ± 8.42 59 38.9 ± 9.86 41 
 
C. Summary of the kinetics of Get3 dissociation from Get4/5 in ATP.   
Ionic 
Strength 
Buffer 
1st Phase 2st Phase 
k-1 (s-1) 
amplitude 
(%) k-2 (s
-1) amplitude (% ) 
150 mM 
KOAc 1.10 ± 0.061 50 0.092 ± 0.004   50 
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Table 2. Summary of the equilibrium binding affinities of Get3’s interaction with 
Get1-CD and Get2-CD. 
 
Receptor Get3 complex Nucleotide Kd (µM) 
Get1 
Get3 
apo 0.055 ± 0.015 
ADP 0.616 ± 0.183 
ATP Not detectable 
Get3/TA 
apo 2.20 ± 0.28 
ADP 2.74 ± 0.003 
ATP Not detectable 
Get2 
Get3 
apo 0.469 ± 0.09 
ADP 0.444 ± 0.126 
ATP 0.90 ± 0.170 
Get3/TA 
apo 1.61 ± 0.006 
ADP 2.74 ± 0.003 
ATP 2.77 ± 0.822 
Mini-Get1/2 
Get3/TA 
apo 0.328 ± 0.006 
Mini-
Get1/2RERR apo 1.85 ± 0.353 
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 Figure 3.1. Nucleotide and substrate govern how Get3 interacts with Get4/5. (A) 
Structure of Get3 (yellow) bound to Get4/5N (red) 48. The zoom in shows the placement 
of the reporter dye on Get4. (B) Equilibrium titrations for the binding of Get3 to Get4/5 
in the apo- (triangle) and ATP-bound (closed circles) states. Data are fit to equation 1 and 
the Kd values are summarized in Table 1A. (C) Equilibrium titrations for binding of the 
Get3/TA complex to Get4/5 in the apo- (cross) and ATP-bound (closed circles) states. 
The data are fit to equation 1 and the Kd values are summarized in Table 1A. The dotted 
line depicts Get4/5 binding to ATP-bound Get3 from part B and is shown for comparison. 
(D) Summary of the binding constants (Kbinding = 1/Kd) of Get4/5 to Get3 and Get3/TA. 
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Figure 3.2. Get3 binds to Get4/5 with rapid dynamics. (A) Time course of Get4/5 
binding to ATP-bound Get3. Arrows indicate the two kinetic phases. (B) Observed 
association rate constants (kobsd) are analyzed as a function of Get3 concentration to 
determine the association rate constant kon for both the first (circles) and second 
(triangles) kinetic phases. The data were fit to equation 2, and the kon values are reported 
in Table 1B. (C) Get3-Get4/5 association rates are highly salt-sensitive. See also Table 
1B. (D) Dissociation rate constants of Get3-ATP from Get4/5. See also Table 1C.  
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Figure 3.3. Interaction of Get3 with Get1-CD or Get2-CD is modulated by nucleotide 
state and TA loading. (A) Fluorescence anisotropy of 200 nM fluorescein-labeled 
Get2CD-T34C (Get2*) and Get1CD-Q62C (Get1*) by itself, in the presence of 2 µM 
Get3 (+Get3), or in the presence of Get3 and excess unlabeled Get1- or Get2-CD 
(+chase). (B – C) Representative equilibrium titrations for binding of Get1* (B) and 
Get2* (C) to apo-Get3 and apo-Get3/TA. 
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Figure 3.4. Capture and handover of Get3/TA by the Get1/2 receptor. (A) Summary of 
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the binding affinity (Kbinding  = 1/Kd) of Get3 for Get2-CD (purple) and Get1-CD (red) in 
different substrate occupancy and nucleotide states. See also Table 2. (B) Binding of the 
Get3/TA complex to 200 nM DACM labeled wildtype mini-Get1/2 (closed circles) or 
mutant mini-Get1/2RERR (open circles). The data were fit to equation 1 and the values 
of Kd are reported in Table 2. Cartoon depicts co-binding of both receptor subunits to the 
Get3/TA complex when a functional Get2 is present. 
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Figure 3.5. The interaction of Get3 with the full-length receptor in proteoliposomes. (A) 
Cartoon depicting the proteoliposome sedimentation assay as described in the Methods. 
(B,C) Results of the sedimentation assay with Get1-PL (part B) and Get2-PL (part C) are 
analyzed by silver-stain of the pellet fraction (upper panel; cf. part A) and quantified 
(lower panel). Get3 contains a 6HIS tag and can therefore be distinguished from Get3/TA 
complexes (untagged). The substrate-loading and nucleotide state of Get3 are indicated. 
See methods for quantification details.  
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Figure 3.6: ATP actively displaces Get3 from Get1. (A) Rate constants for dissociation 
of a preformed Get3•Get1-CD(DACM-labeled) complex, driven by either 2 mM ATP 
(orange) or 8.5 µM unlabeled Get1-CD (black). (B) Rate constants for dissociation of the 
Get3•mant-ATP complex, driven by either 2 mM ATP (orange) or 2.5 µM Get1-CD 
(black).  
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Figure 3.7 Get4/5 is necessary for recycling Get3 from the receptor complex in the 
membrane. (A) Release of Get3 from full-length Get1-PL. 50 nM His6-Get3 was pre-
incubated with Get1-PL for 15 minutes and chased with the indicated factors for 10 
minutes. Proteoliposomes were sedimented as in Figure 5, and His6-Get3 was detected 
by western blot using anti-His antibody. (B) Same as in (A) except that Δget3 microsomal 
membranes were used instead of proteoliposomes, and both the soluble and pellet 
fractions were analyzed. (C) Quantification of the results in (B).  
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Figure 3.8: (A) Model for TA targeting, insertion and Get3 recycling at the ER 
membrane, as described in the text. (B) Cartoon depicting the differential binding 
affinities of Get3 for Get4, Get2 and Get1 in different substrate and nucleotide states, as 
described in the text. 	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Chapter 4 
 
The mechanism of Get3 binding to Get4/5 
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Get3 binds to Get4/5 in an asymmetric configuration 
 Given the configuration of Get4/5 as a heterotetramer (2 copies of Get4 and Get5), 
it is strongly expected that both arms of Get4 are accessible for binding Get3. 
Surprisingly, the equilibrium titration data for Get3-Get4/5 binding can only fit to a 
stoichiometry in which each Get3 monomer binds two copies of Get4 and Get5 (1:2), i.e., 
a Get4/5 tetramer (Fig. 1A), but not to a 1:1 stoichiometry that allows Get3 to bind both 
copies of Get4 in the Get4/5 complex (Figure 1B). This strongly suggests an asymmetry 
in the full length Get4/5 complex, in which only one arm of the Get4/5 tetramer is 
functional in binding Get3.  
 To directly test the asymmetry in Get4/5 during Get3 binding, we developed an 
alkylation assay coupled with mass spectrometry to assess the accessibility of an 
engineered cysteine, Get4(C48), at the Get3-Get4/5 interface (Fig. 2A, Fig. S1A; 61).  In 
the free Get4/5 complex, Get4(C48) is solvent exposed 25 and rapidly alkylated to 
completion by N-ethyl-maleimide (NEM; Fig. 2B, black). If both copies of Get4 in the 
Get4/5 complex can bind Get3, C48 is rendered solvent inaccessible (Fig. 2A) and will be 
completely protected from alkylation. In contrast, if only one copy of Get4 in Get4/5 is 
bound to Get3, only half of the Get4 molecules can be protected. Consistent with 
expectations from the latter model, only 50% of Get4(C48) was protected from alkylation 
by Get3 throughout the time course relative to free Get4/5 (Fig. 2B, red). This protection 
pattern was observed at a Get3 concentration nearly 1000 fold above the dissociation 
constant for the Get3•Get4/5 complex, indicating that the 50% protection did not arise 
from incomplete Get3-Get4/5 binding. These results strongly suggest that one arm of a 
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Get4/5 tetramer is able to bind to Get3, while the other arm becomes either allosterically 
inactivated.  
 We followed up the results of the alkylation assay by probing accessibility of 
Get4/5 using PEG-	  Maleimide 10kDa. To rule out the possibility that Get4 S48 is 
partially exposed to solvent when bound to Get3, we picked a position on Get4 (Q34C) 
that is completely occluded in the Get3-Get4/5N closed structure (Fig. 2C). Substitution 
of Q34 does not impair binding to Get3 and has little sequence conservation 25.  As 
expected, when Get4(Q34C/C177T)/Get5 is incubated with PEG-Maleimide, a 10kDa 
shift is observed in the molecular mass of the Get4/5 complex (Figure S1B). Carrying out 
this reaction over a two-minute time course in the absence of Get3 resulted in 100% 
Get4/5 pegylation, whereas the addition of Get3 resulted in 50% pegylation (Fig. 2D). 
This provides corroborating evidence that only one arm of the Get4/5 heterotetramer is 
able to bind Get3. 
 
Sequential	  binding	  of	  two	  Get4/5	  molecules	  to	  Get3	  
	  
 We recently showed that Get3 binds full-length Get4/5 with tight affinity (Kd = 
3.2 nM) yet fast dynamics (kon = ~ 108 M-1 s-1, koff= ~0.5 s-1) (Chapter 3). Moreover, 
association rate measurements showed two distinct concentration dependent phases that 
differed by ≤6-Fold. The first kinetic phase was extremely sensitivity to buffer ionic 
strength (Chapter 3), demonstrating that electrostatic contacts drive fast complex 
formation. Surprisingly, analysis of the second slower kinetic phase revealed no changes 
in association rate constants when buffer ionic strength was varied (Fig. 2A). The 
simplest model to account for the presence of biphasic kinetics, differences in salt 
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sensitivity, and two distinct crystallographic binding interfaces would be the sequential 
interaction of two Get4/5 molecules on opposite interfaces of the Get3 dimer (Fig. 5). We 
propose a three-step binding model: 1) Ge4/5 initially forms a rapid electrostatically 
driven encounter complex with the first interface in a semi-open Get3 dimer.  2) Get4/5 
binding to the semi-open Get3 complex induces a fast unimolecular rearrangement to an 
‘occluded’ conformation. 3) Binding of the second Get4/5 molecule then occurs to the 
available binding interface on Get3.  
The full-length Get4/5 protein is a heterotetrameric complex containing two 
copies of Get4 each associated with a one half of a Get5 dimer 25. This raises the 
possibility that the observed biphasic kinetics is due to binding of another Get3 dimer to 
the Get4/5 heterotetramer.  In order to test this possibility, we carried out association rate 
measurements with tetramerization-deficient Get4/5N. The results show that Get4/5N 
binds Get3 with identical kinetics to full-length Get4/5 (Fig. 3 B,C). Importantly, the first 
concentration dependent phase was sensitive to differences in buffer ionic strength (Fig. 
3D). Since these distinct binding trends are perfectly recapitulated with the monomeric 
Get4/5N, this rules out the alternative model that the second phase arises from a second 
Get3 dimer binding to the other arm in the full-length Get4/5 heterotetramer. Coupled 
with the above stoichiometry data, this provides additional evidence that distinct Get4/5 
molecules sequentially bind to the Get3 dimer. 
 
Binding of the first Get4/5 molecule induces a conformational change in Get3 
For the faster-binding population of Get3, the initial association with Get4/5 is 
unstable, with a dissociation rate constant of 15 s-1 (Chapter 3). The equilibrium stability 
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of this initially assembled complex, derived from the koff and kon values, is 107 nM, 
approaching the Kd value of the apo-Get3•Get4 complex (~200nM). However, both the 
equilibrium and kinetic stability of the stably assembled Get3•Get4/5 complex are >15-
fold higher than these values. Thus a conformational change must occur after the rapid 
initial assembly of Get3 with Get4/5 to give a more stable complex. The detection of a 
conformation change in our kinetic data is consistent with previous results showing that 
Get4/5 biding induces Get3 into an occluded conformational state, leading to Get3 
ATPase inhibition and delayed ATP dissociation kinetics 62. 
Since the binding of the second Get4/5 molecule is not sensitive to changes in 
buffer ionic strength (Fig. 3A), the preceding conformational change must rearrange the 
Get3-Get4/5 binding interface (corroborating structural evidence provided in the next 
section). The model thus predicts that once Get3 has transitioned to the occluded 
conformation, complex dissociation would be insensitive to buffer ionic strength. In order 
to test this idea, we measured the dissociation rate of the ATP bound Get3-Get4/5 
complex in buffer containing either no salt or 350 mM NaCl. In agreement with 
predictions from association rate measurements, complex dissociation was insensitive to 
buffer ionic strength (Fig. 4A), demonstrating that the stable Get3-Get45 complex is held 
together largely by hydrophobic interactions.  
In order to rule out a model where two different populations of Get3 give rise to 
the observed binding and dissociation kinetics, we analyzed the magnitude of each 
kinetic phase as a function of Get3 concentration and salt concentration (Fig. 4B). The % 
amplitude of the two kinetic phases during Get3-Get4/5 association is not altered by 
changes in ionic strength, despite the >30-fold changes in the relative association rates of 
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the salt-sensitive and -insensitive phases (Fig. 4B). This behavior is not expected if these 
two phases arise from heterogeneity among Get3 dimers (as the faster-binding population 
will become more dominant in magnitude), but can be explained if the salt-sensitive 
phase is an obligatory initial association step that must precede binding of the second 
Get4/5 to a Get3 dimer. 
Further evidence for a conformational change is evident when analyzing 
dissociation of Get3 from Get4/5 in different nucleotide states. The magnitude of the 
slow phase during dissociation increases successively when apo-Get3 is compared with 
ADP- and ATP-bound Get3 (Fig. 4C). This indicates that the two phases are governed in 
part by a reversible conformational change that can be induced by nucleotides, with ATP 
being more effective than ADP. This is consistent with previous structural, kinetic and 
molecule simulations data, showing that ATP is more effective than ADP in inducing 
Get3 into a closed conformation 3,25. 
 
Kinetic modeling of Get3’s interaction with Get4/5 
 Combining our structural, biochemical and quantitative binding data, we sought to 
model the Get3-Get4/5 interaction using kinetic simulation software 63. We assigned 
individual rate constants to each step in the Get3-Get4/5 binding model based off 
simulations from the modeling algorithm (Fig 5). Using the experimentally derived 
values for kon and koff from both the salt and salt-insensitive phases, we were able to 
completely reproduce the biphasic trends observed in association/dissociation rate 
measurements, and equilibrium titrations (Fig. 6A,B,C). These trends were only found 
when we modeled a conformational change in Get3 upon binding the first Get4/5 
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molecule. Since these simulations completely recapitulate experimental data, this 
provides strong evidence for the binding model presented in Figure 5. 
 
Preliminary	  data:	  The	  Get3-­‐Get4/5	  interface	  is	  remodeled	  once	  Get3	  acquires	  
TA	  substrate	  
	  
 Together with the ~20-fold weaker binding of Get3/TA complex to Get4/5, this 
suggests a change in the conformation at the Get3-Get4 interaction interface. In support 
of this notion, in the Get4/5•Get3/TA complex Get4(C48) is alkylated by NEM as 
efficiently as in free Get4/5, (Figure 3D, green). Together, these data support a model in 
which each copy of Get3 in a Get3 dimer first binds one copy of Get4 in the Get4/5 
heterotetramer, rendering the other arm of Get4/5 unoccupied. The loading of the TA 
substrate (by Sgt2 or other chaperones) drives tetramerization of Get3, forcing the other 
arm of Get4/5 to also bind Get 3.  This could generate a ‘strained’ conformation in the 
Get4/5 heterotetramer that explains its weakened affinity to the Get3/TA complex than to 
free Get3, thus enabling the facile release of the targeting complex from Get4/5. 
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Table 1 
Summary of the kinetics of Get3 dissociation from Get4/5 in ATP.   
Ionic 
Strength 
Buffer 
1st Phase 2st Phase 
k-1 (s-1) 
amplitude 
(%) k-2 (s
-1) amplitude (% ) 
350 mM 
NaCl 0.924 ± 0.029 32.7 0.100 ± 0.001 67.3 
No  
Salt 0.769 ± 0.037 41.7 0.080 ± 0.003 58.3 
 
 
Table 2 
 
Summary of the kinetics of Get3-Get4/5-N association in ATP.  
 
Ionic 
Strength 
Buffer 
1st phase 2nd Phase 
k1 (µM-1 s-1) k2 (µM-1 s-1) 
150 mM 
KOAc 101.5 ± 3.2 12.6 ± 0.291 
350 mM 
NaCl 8.3 ± 1.7 5.6 ± 0.90 
90 mM 
NaCl 117 ± 15.5 5.6 ± 0.92 
5 mM 
NaCl 238 ± 35 N/A 
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Table 3 
 
Comparison of experimental and simulation data 
 
Experimental Association Rate       Simulated Association Rate 
1st phase 2nd Phase 1
st phase 2nd Phase 
 k1 (µM-1 s-1) k2 (µM-1 s-1) k1 (µM-1 s-1) k2 (µM-1 s-1) 
143.8 43.5 175 40.6 
 
 
Experimental Dissociation Rate       Simulated Dissociation Rate 
1st phase 2nd Phase 1
st phase 2nd Phase 
 k1 (s-1) k2 (s-1) k1 (s-1) k2 (s-1) 
0.64 0.10 0.79 0.075 
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  Figure	  4.1.	  Stochiometry	  of	  the	  Get3-­‐Get4/5	  complex.	  (A)	  Cartoon	  depicting	  a	  1:2	  binding	  stoichiometry	  of	  Get3	  with	  Get4/5.	  This	  configuration	  was	  used	  to	  fit	  an	  equilibrium	  titration	  of	  ACR-­‐labeled	  Get4/5-­‐FL	  (100nM)	  with	  Get3	  in	  2mM	  ATP.	  (B)	  Same	  as	  in	  A,	  but	  with	  a	  1:1	  binding	  stoichiometry.	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  Figure	  4.2.	  Probing	  the	  stoichiometry	  of	  the	  Get3-­‐Get4/5	  complex	  using	  chemical	  modification.	  (A)	  Cartoon	  depicting	  the	  NEM	  accessibility	  of	  a	  solvent	  exposed	  Cys	  (C48)residue	  on	  Get4/5	  alone	  or	  when	  in	  complex	  Get3.	  (B)	  Results	  of	  the	  Alklyation	  assay,	  setup	  shown	  in	  A.	  	  (C)	  PDB	  image	  depicting	  the	  location	  of	  Q34C	  on	  the	  Get3-­‐Get4/5	  structure.	  (D)	  Results	  of	  a	  PEGylation	  assay	  with	  Cys	  (Q34C)	  residue	  on	  Get4/5	  alone	  or	  when	  in	  complex	  with	  Get3.	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  Figure	  4.3.	  Sequential	  binding	  of	  two	  Get4/5	  molecules	  to	  Get3.	  (A)	  Summary	  of	  association	  rate	  constants	  in	  different	  salt	  concentrations	  for	  the	  2nd	  kinetic	  phase	  in	  Get3-­‐Get4/5	  ON	  rate	  measurements.	  (B) Time course of Get4/5N binding to ATP-
bound Get3. Arrows indicate the two kinetic phases. (C) Observed association rate 
constants (kobsd) are analyzed as a function of Get3 concentration to determine the 
association rate constant kon for both the first (circles) and second (triangles) kinetic 
phases. (D) Get3-Get4/5N association rates are highly salt-sensitive.  
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  Figure	  4.4.	  Get4/5	  undergoes	  a	  conformational	  change	  upon	  binding	  Get3.	  (A)	  Dissociation	  rate	  measurement	  of	  Get3	  from	  Get4/5	  in	  350mM	  NaCl	  (red)	  and	  no	  salt	  (blue).	  (B) The amplitude of the 1st kinetic phase for Get3-Get4/5 association in 
different salt concentrations is invariant to buffer ionic strength. (C) Percent amplitude of 
the 2nd kinetic phase for Get3 dissociation from Get4/5N in different nucleotide states. 	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  Figure	  4.5.	  Kinetic	  model	  for	  the	  interaction	  of	  Get3	  with	  Get4/5	  as	  described	  in	  the	  text.	  All	  steps	  simulated	  with	  Kintek	  modeling	  software.	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  Figure	  4.6.	  Comparison	  of	  experimental	  (black)	  and	  theoretical	  (red)	  biding	  data	  for	  the	  Get3-­‐Get4/5	  complex.	  Values	  report	  in	  Table	  3.	  (A)	  Association	  rate	  measurements,	  (B)	  Dissociation	  rate	  measurements,	  (C)	  Equilibrium	  titrations.	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  Figure	  4.7.	  Probing	  the	  stoichiometry	  of	  the	  Get3/TA-­‐Get4/5	  complex	  using	  chemical	  modification.	  NEM	  accessibility	  of	  a	  solvent	  exposed	  Cys	  (C48)residue	  on	  Get4/5	  alone	  or	  when	  in	  complex	  Get3/TA	  .	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Appendix A: Supplemental Data for Chapter 2 
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Figure 2.S1:  
Assays for ATP binding and hydrolysis by Get3, related to Figure 1 and Figure 2. (A) 
Representative thin layer chromatography (TLC) analysis for monitoring the progress of 
a Get3 ATPase reaction (see Methods). Right panel shows quantification of the TLC data, 
which were fit to a single exponential function to obtain observed rate constants (kobsd). 
(B) Fluorescence emission spectra of 0.4 µM mantATP with (red) or without (black) 35.8 
µM Get3, and for the Get3-mantATP complex chased with 2 mM ATP (blue). (C) 
102 
Fluorescence emission spectra for 1.2 μM Get3 (donor, blue), 60 μM mantATP (acceptor, 
green), 1.2 µM Get3 incubated with 60 µM mantATP (donor + acceptor, red), or buffer 
(gray). 
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Figure 2.S2:  
Mant-ATP and mant-ADP binding and dissociation to Get3 related to Figure 1 and 
Figure 2. (A) Competition of mantATP binding to Get3 by ATP, performed with 1.5 µM 
Get3, 8 µM mantATP, and varying concentrations of ATP as indicated. The data were fit 
to Eq 2 in Methods, which gave a Ki,app value of 4.5 μM. (B) Single-site time courses for 
mantATP (black) or mantADP (gold) binding to 37 µM Get3.  (C) Single-site observed 
association rate constants were plotted as a function of Get3 concentration.  Linear fits of 
the data (Eq 4) gave kon values of 0.20 ± 0.01 and 0.29 ± 0.02 µM-1s-1 for ATP (black) and 
ADP (gold), respectively. The values reported are the mean ± SD, with n = 3. (D) Multi-
site time courses for binding of 13 µM mantATP (black) or mantADP (gold) to 1.5 µM 
Get3 using the FRET assay (E) Multi-site observed nucleotide binding rate constants 
were plotted as a function of Get3 concentration.  Linear fits of the data gave kon values of 
0.43 ± 0.04 µM-1 s-1 for ATP (black) and 0.31 ± 0.03 µM-1 s-1 for ADP (gold). (F) Time 
courses for mantATP (black) or mantADP (gold) dissociation from Get3 under multi-site 
conditions. The data were fit to double exponential functions. Rate constants derived 
from the fast phase are reported in the text and table S1.  
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Figure 2.S3: 
Controls for Get3 concentration-dependent ATPase stimulation, related to Figure 3. (A) 
Zoom-in of the dependence of observed kcat values at low Get3 concentrations. Reactions 
were performed as in Figure 3A in the presence of 1mg/mL BSA (see methods). (B) 
Dependence of observed kcat of Get3 in assay buffer (circles, see Methods) or purification 
buffer (squares; 10 mM Tris, pH 7.5, 150 mM NaCl, 1 mM MgCl2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
106 
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Figure 2.S4: 
Targeting and translocation of TA protein by wildtype and mutant Get3, related to Figure 
3. (A) Cartoon diagram of the Get3 dependent TA targeting and translocation assay, as 
described in the Experimental Procedures and text. (B) Get3-dependent targeting and 
translocation of Sbh1p, performed under identical conditions to Figure 3C, but in an 
independent experiment on a separate day using different Get3 concentrations. The data 
were analyzed as in Figure 3C and gave a Hill coefficient of 2. (C) Sbh1p targeting and 
translocation by wildtype and mutants PM199DD, ML200DD, and Δ181-210 at high 
Get3 concentrations. Gels for the data are on the right panel. (D) Capture of Sbh1p by 
wildtype Get3 (left) and mutant (Δ181-210) (right), using pulldown of His6-tagged Get3 
by Ni-NTA beads as described in the Experimental Procedures. 
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Figure 2.S5: 
Get4/5 increases Get3’s affinity for ATP, and vice versa. Related to Figure 4. (A) ATP 
concentration dependence of observed ATPase activity at 1 µM Get3, in the absence 
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(black) and presence (red) of 5 µM Get4/5. The data were fit to Eq 8 in the Extended 
Experimental Procedures, and gave average KM values of 3.6 ± 0.01 and 2.2 ± 1.0 µM, 
and kcat values of 0.43±0.003 and 0.18±0.04 min-1 with and without Get4/5, respectively. 
(B) Get3•mantATP dissociation kinetics, determined in the presence (red) or absence 
(black) of 3.0 µM Get4/5. Exponential fits of data gave dissociation rate constants of 14.4  
s-1 and 11.3 s-1 with and without Get4/5, respectively. (C) Gel filtration chromatogram of 
apo-Get3 without (black) or with (red) Get4/5. Shown is a gel image for the fractions 
collected at ~11 ml. (D) Same as (C) but in the presence of saturating ATP. 
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Figure 2.S6: 
Purification and activity of the Get3/TA complex, related to Figure 5. (A) Purification of 
the recombinant Get3/TA complex over Superdex 200 (green). Maltose binding protein 
(MBP) was a cleavage product from MBP-tagged Get3 during the purification, as 
described in the Methods. Chromatogram for dimeric Get3 is shown in black. Right panel 
shows SDS-PAGE analysis of the elution peak at ~10 ml, which contain both Get3 and 
Sbh1p. (B) Pre-steady-state ATPase reaction from the Get3/TA complex, performed as in 
Figure 6A but with different ratios of Get3/TA complex relative to ATP: 1:10 (light 
green), 1:5 (green), 1:2.5 (dark green). Data were analyzed as in Figure 5A.  (C, D) 
Representative time course for mantATP binding to the Get3/TA complex under multi-
site (C) and single-site (D) conditions. Reaction in (C) used 2 µM Get3/TA complex and 
13 µM mantATP and the obtained rate constants are plotted in Figure 6C. Reaction in (D) 
used 12.5 µM Get3/TA complex and 0.4 µM mantATP, and double exponential fit of the 
111 
data gave rate constants of 0.4 s-1 and 0.073 s-1. (E) Dissociation rate measurements for 
the Get3/TA complex in various nucleotide states. 2 µM Get3/TA was preincubated with 
20 µM of the following: mantATP (black), mantADP (gold), mantAMPPNP (grey), and 
ADP + 10 mM Pi (blue). Dissociation rate constants are reported in Table S2. 
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Figure 2.S7:  
MantATP binding to Get3 is biphasic, related to Figure 2, and described in Extended 
Experimental Procedures. (A, B) Time course for mantATP binding to Get3 under single-
site (A) and multi-site (B) conditions. The data were fit to double exponential functions. 
Rate constants derived from the fast phase are reported in the text. (C, D) Time courses 
for mantATP (C) or mantADP (D) dissociation from Get3 under multi-site conditions. 
The data were fit to double exponential functions. Rate constants derived from the fast 
phase are reported, as explained in the Extended Experimental Procedures. 
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Appendix B: Supplemental Data for Chapter 3 
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Figure 3.S1. Overlay of the binding sites of Get4 and Get2 (left), and Get4 and Get1 
(right) on the Get3 dimer 48.   
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Figure 3.S2. Interaction of Get3 with Get4/5, related to Figure 1. (A) Fluorescence 
emission spectra of 100 nM acrylodan-labeled Get4/5 with (black) and without (red) 500 
nM Get3. (B) Multi-turnover ATPase assay with 2.0 µM Get3 alone or in complex with 
8.0 µM wild type (black) or acrylodan-labeled (red) Get4/5. All assays contained 200 µM 
ATP. 
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Figure 3.S3. The interaction of Get3 with Get1- and Get2-CD, related to Figs 3 and 4. 
(A) Fluorescence emission spectra of 150 nM DACM-labeled Get1 alone (red) or in the 
presence of the following: 400 nM Get3 present (blue), 400 nM Get3 and 2.3 mM ATP 
(green), or 400 nM Get3, 2.3 mM ATP and 17 µM unlabeled Get1 (orange). (B) Pull-
down assay with His6-tagged Get3 and untagged wildtype Get2 or Get2 T34C. Controls 
with no Get3-His6 are shown for comparison. (C) Summary of the fluorescence 
anisotropy endpoints for the complexes of Get1-CD and Get2-CD with the Get3/TA 
complex in the ADP- or apo-states. 
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Figure 3.S4. The interaction of Get3 with mini-Get1/2, related to Figure 4. (A) 
Coomassie stained image (left) and UV-excited fluorescence image (right) of SDS-PAGE 
of DACM-labeled proteins: mini-Get1/2 (lane 1), mini-Get1/2RERR (lane 2), and Get1-
CD (lane 3). (B) Fluorescence emission spectra of 150 nM DACM-labeled mini-Get1/2 
alone (red) or in the presence of the following: 2 µM Get3/TA (blue), or 2 µM Get3/TA 
and 2.0 mM ATP (green).  
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Figure 3.S5. Reagents for generating Get1/2-PL, related to Figure 5. (A) SDS-PAGE 
showing the purification of full-length Get1 and Get2 in detergent, as described in 
methods. (B) Silver-stained gel containing Get2-PL and increasing amounts of 
recombinant Get2. Band intensity of Get2 in PL was quantified using known amounts of 
recombinant Get2 as a standard for concentration determination. (C) same as (B) but 
using Get1-PL. 
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Figure 3.S6. In vivo assay for TA targeting based on Kar2p secretion, related to Figure 7. 
Western blot of secreted Kar2p from the indicated yeast strains (wild type, Δget3, Δget4, 
Δsgt2), detected using an anti-Kar2p antibody. Quantification of secreted Kar2p is shown 
below the western blot. 
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Appendix C: Supplemental Data for Chapter 4 
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Figure 4.S1. Controls for accessibility experiment, related to Figure 2. (A) Molecular 
weight (determined by MSD) of the unmodified and modified (NEM-reacted) Get4 
protein. (B) Time course for PEGylation of Q34C on Get4. 
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